Opportunity ID: 328396

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-DP21-2106
Funding Opportunity Title: Advancing Arthritis Public Health Priorities through National Organizations
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 7
Assistance Listings: 93.945 — Assistance Programs for Chronic Disease Prevention and Control
Cost Sharing or Matching Requirement: No
Version: Synopsis 23
Posted Date: Jan 14, 2021
Last Updated Date: Aug 12, 2021
Original Closing Date for Applications: Apr 05, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Current Closing Date for Applications: Apr 05, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Aug 14, 2021
Estimated Total Program Funding: $10,185,595
Award Ceiling: $1,000,000
Award Floor: $150,000

Eligibility

Eligible Applicants: For profit organizations other than small businesses
Independent school districts
Native American tribal governments (Federally recognized)
County governments
Public and State controlled institutions of higher education
City or township governments
State governments
Special district governments
Public housing authorities/Indian housing authorities
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Native American tribal organizations (other than Federally recognized tribal governments)
Private institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: This NOFO has two Components. Component 1 is focused on Building Capacity & Scaling Up whereas Component 2 is focused on Innovation. Applicants may apply for either or both Component 1 or Component 2. Component 1 applicants must select only one of the four options (A, B, C or D). Applicants must identify the Component they are applying for in the title of their application submission. If not clearly identified, the application will be considered non-responsive and will not be entered into the review process. A separate application must be submitted for each Component if applying for more than one.

Applicants are required to submit a budget within the range noted for each Component and corresponding strategy. If the proposed budget exceeds the Component and Strategy funding range, the application will be considered non-responsive and will not be entered into the review process.

Component 1 Funding Range:

Strategy A – $300K-$500K
Strategy B – $150K-$250K
Strategy C – $400K-$500K
Strategy D – $200K-$300K

Component 2 Funding Range – $300K-$500K

Additional Information

Agency Name: Centers for Disease Control – NCCDPHP
Description: The CDC Arthritis Program is announcing a new, FY21 non-research NOFO designed to improve health and quality of life for people with arthritis. Arthritis is an oft overlooked, leading contributor to chronic disease burden and a top cause of morbidity, work limitations, and reduced quality of life. More than 54 million US adults1 have arthritis, half of whom are working age2; and 78 million are projected to have it by 20403. Arthritis is significant, not only because it limits physical function and quality of life, but because it commonly co-occurs with other chronic conditions that are leading causes of death, such as heart disease, diabetes, and obesity, and can interfere with management of these conditions through its effects on limiting physical activity (PA)2.
 
People with arthritis face barriers to PA such as fear of worsening arthritis pain and progression2. However, arthritis and its limitations can be managed effectively, and symptoms improved through routine PA and participation in self-management education (SME) programs2. Low-cost, arthritis-appropriate, evidence-based interventions (AAEBIs) shown to decrease arthritis pain and/or disability and improve quality of life are available in geographic pockets across the US but are still underused by people who can benefit from them2. Lack of awareness about AAEBIs, their benefits, and how to access them remain a challenge and a barrier to participation in these programs. More AAEBI offerings are needed, with greater geographic dispersion; and greater awareness to increase participation in them.
 
This NOFO will leverage and expand existing systems, technologies and networks with national reach and/or access into large segments of the adult population to sustainably increase awareness and availability of and participation in AAEBIs. It will also support technical assistance to state health departments and provision of arthritis-specific consumer health information to the public. Further, it will facilitate collaborative action to address osteoarthritis (OA) and address health equity and social determinants affecting AAEBI awareness and access and adoption of effective self-management behaviors. Lastly, it will support development of a national strategy targeted at healthcare providers to complement pharmacological treatments by specifically emphasizing adjunct self-management and physical activity approaches. The NOFO goals are to enhance the health, wellness, and quality of life of adults with arthritis and improve arthritis management and health outcomes.
 
References:

Barbour KE, Helmick CG, Boring M, Brady TJ. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013-2015. MMWR 2017;66(9):246-253.
Barbour, K. E., Helmick, C. G., Boring, M., & Brady, T. J. (2017). Vital signs: prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013–2015. MMWR 2017;66(9):246.
Hootman JM, Helmick CG, Barbour KE, Theis KA, Boring MA. Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015-2040. Arthritis Rheumatol. 2016;68(7):1582-7.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Michele Mercier
zaf5@cdc.gov
Email:zaf5@cdc.gov

Version History

Version Modification Description Updated Date
NOA updates Aug 12, 2021
This amendment is being issued to correct NOFO information for the record. Jan 14, 2021
Applications are not being accepted at this time. The NOFO is closed. Jan 14, 2021
Applications are not being accepted at this time. The NOFO is closed. Jan 14, 2021
Applications are not being accepted at this time. The NOFO is closed. Jan 14, 2021
Applications are not being accepted at this time. The NOFO is closed. Jan 14, 2021
Applications are not being accepted for this announcement. This announcement has closed. Jan 14, 2021
Applications are not being accepted for this announcement. This announcement has closed. Jan 14, 2021
Applications are not being accepted for this announcement. This announcement has closed. Jan 14, 2021
Applications are not being accepted for this announcement. This announcement has closed. Jan 14, 2021
This announcement is no longer accepting new applications. This opportunity is closed". Jan 14, 2021
This announcement is no longer accepting new applications. This opportunity is closed". Jan 14, 2021
This announcement is no longer accepting new applications. This opportunity is closed". Jan 14, 2021
This announcement is no longer accepting new applications. This opportunity is closed". Jan 14, 2021
This announcement is no longer accepting new applications. This opportunity is closed". Jan 14, 2021
This announcement is no longer accepting new applications. This opportunity is closed". Jan 14, 2021
This announcement is no longer accepting new applications. This opportunity is closed". Jan 14, 2021
This announcement is no longer accepting new applications. This opportunity is closed". Jan 14, 2021
Due to an update in our application packages on Grants.gov, if you retrieved a package before today March 24, 2021, you will have to retrieve an updated application package with the new versions of the updated forms.
If you have any questions please contact ogstims@cdc.gov.
Jan 14, 2021
Minor changes made to NOFO content Jan 14, 2021
1. Resolved a minor inconsistency in the NOFO related to the estimated award range. The award range on page 9 was changed to reflect $150K for the statement, “Component 1 is focused on Building Capacity & Scaling Up non-research efforts to address arthritis. It comprises 5-7 awards of $200-$500K each.”

2. Changed the number of required AAEBIs for Component 1, Strategy 1 from “offering at least two AAEBIs” to “offering at least one AAEBI.”

3. Added the following to the “Additional Information on Eligibility” section:

Applicants are required to submit a budget within the range noted for each Component and corresponding strategy. If the proposed budget exceeds the Component and Strategy funding range, the application will be considered non-responsive and will not be entered into the review process.

Component 1 Funding Range:
• Strategy A – $300K-$500K
• Strategy B – $150K-$250K
• Strategy C – $400K-$500K
• Strategy D – $200K-$300K

Component 2 Funding Range – $300K-$500K

Jan 14, 2021
Updates made to Eligibility and GMS Assignment Jan 14, 2021
Jan 14, 2021
Jul 29, 2020

DISPLAYING: Synopsis 23

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-DP21-2106
Funding Opportunity Title: Advancing Arthritis Public Health Priorities through National Organizations
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 7
Assistance Listings: 93.945 — Assistance Programs for Chronic Disease Prevention and Control
Cost Sharing or Matching Requirement: No
Version: Synopsis 23
Posted Date: Jan 14, 2021
Last Updated Date: Aug 12, 2021
Original Closing Date for Applications: Apr 05, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Current Closing Date for Applications: Apr 05, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Aug 14, 2021
Estimated Total Program Funding: $10,185,595
Award Ceiling: $1,000,000
Award Floor: $150,000

Eligibility

Eligible Applicants: For profit organizations other than small businesses
Independent school districts
Native American tribal governments (Federally recognized)
County governments
Public and State controlled institutions of higher education
City or township governments
State governments
Special district governments
Public housing authorities/Indian housing authorities
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Native American tribal organizations (other than Federally recognized tribal governments)
Private institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: This NOFO has two Components. Component 1 is focused on Building Capacity & Scaling Up whereas Component 2 is focused on Innovation. Applicants may apply for either or both Component 1 or Component 2. Component 1 applicants must select only one of the four options (A, B, C or D). Applicants must identify the Component they are applying for in the title of their application submission. If not clearly identified, the application will be considered non-responsive and will not be entered into the review process. A separate application must be submitted for each Component if applying for more than one.

Applicants are required to submit a budget within the range noted for each Component and corresponding strategy. If the proposed budget exceeds the Component and Strategy funding range, the application will be considered non-responsive and will not be entered into the review process.

Component 1 Funding Range:

Strategy A – $300K-$500K
Strategy B – $150K-$250K
Strategy C – $400K-$500K
Strategy D – $200K-$300K

Component 2 Funding Range – $300K-$500K

Additional Information

Agency Name: Centers for Disease Control – NCCDPHP
Description: The CDC Arthritis Program is announcing a new, FY21 non-research NOFO designed to improve health and quality of life for people with arthritis. Arthritis is an oft overlooked, leading contributor to chronic disease burden and a top cause of morbidity, work limitations, and reduced quality of life. More than 54 million US adults1 have arthritis, half of whom are working age2; and 78 million are projected to have it by 20403. Arthritis is significant, not only because it limits physical function and quality of life, but because it commonly co-occurs with other chronic conditions that are leading causes of death, such as heart disease, diabetes, and obesity, and can interfere with management of these conditions through its effects on limiting physical activity (PA)2.
 
People with arthritis face barriers to PA such as fear of worsening arthritis pain and progression2. However, arthritis and its limitations can be managed effectively, and symptoms improved through routine PA and participation in self-management education (SME) programs2. Low-cost, arthritis-appropriate, evidence-based interventions (AAEBIs) shown to decrease arthritis pain and/or disability and improve quality of life are available in geographic pockets across the US but are still underused by people who can benefit from them2. Lack of awareness about AAEBIs, their benefits, and how to access them remain a challenge and a barrier to participation in these programs. More AAEBI offerings are needed, with greater geographic dispersion; and greater awareness to increase participation in them.
 
This NOFO will leverage and expand existing systems, technologies and networks with national reach and/or access into large segments of the adult population to sustainably increase awareness and availability of and participation in AAEBIs. It will also support technical assistance to state health departments and provision of arthritis-specific consumer health information to the public. Further, it will facilitate collaborative action to address osteoarthritis (OA) and address health equity and social determinants affecting AAEBI awareness and access and adoption of effective self-management behaviors. Lastly, it will support development of a national strategy targeted at healthcare providers to complement pharmacological treatments by specifically emphasizing adjunct self-management and physical activity approaches. The NOFO goals are to enhance the health, wellness, and quality of life of adults with arthritis and improve arthritis management and health outcomes.
 
References:

Barbour KE, Helmick CG, Boring M, Brady TJ. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013-2015. MMWR 2017;66(9):246-253.
Barbour, K. E., Helmick, C. G., Boring, M., & Brady, T. J. (2017). Vital signs: prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013–2015. MMWR 2017;66(9):246.
Hootman JM, Helmick CG, Barbour KE, Theis KA, Boring MA. Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015-2040. Arthritis Rheumatol. 2016;68(7):1582-7.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Michele Mercier
zaf5@cdc.gov
Email:zaf5@cdc.gov

DISPLAYING: Synopsis 22

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-DP21-2106
Funding Opportunity Title: Advancing Arthritis Public Health Priorities through National Organizations
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 7
Assistance Listings: 93.945 — Assistance Programs for Chronic Disease Prevention and Control
Cost Sharing or Matching Requirement: No
Version: Synopsis 22
Posted Date: Jan 14, 2021
Last Updated Date: Aug 12, 2021
Original Closing Date for Applications:
Current Closing Date for Applications: Apr 05, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Aug 14, 2021
Estimated Total Program Funding: $10,185,595
Award Ceiling: $1,000,000
Award Floor: $150,000

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
State governments
For profit organizations other than small businesses
City or township governments
Independent school districts
Native American tribal governments (Federally recognized)
Private institutions of higher education
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Small businesses
County governments
Special district governments
Additional Information on Eligibility: This NOFO has two Components. Component 1 is focused on Building Capacity & Scaling Up whereas Component 2 is focused on Innovation. Applicants may apply for either or both Component 1 or Component 2. Component 1 applicants must select only one of the four options (A, B, C or D). Applicants must identify the Component they are applying for in the title of their application submission. If not clearly identified, the application will be considered non-responsive and will not be entered into the review process. A separate application must be submitted for each Component if applying for more than one.

Applicants are required to submit a budget within the range noted for each Component and corresponding strategy. If the proposed budget exceeds the Component and Strategy funding range, the application will be considered non-responsive and will not be entered into the review process.

Component 1 Funding Range:

Strategy A – $300K-$500K
Strategy B – $150K-$250K
Strategy C – $400K-$500K
Strategy D – $200K-$300K

Component 2 Funding Range – $300K-$500K

Additional Information

Agency Name: Centers for Disease Control – NCCDPHP
Description: The CDC Arthritis Program is announcing a new, FY21 non-research NOFO designed to improve health and quality of life for people with arthritis. Arthritis is an oft overlooked, leading contributor to chronic disease burden and a top cause of morbidity, work limitations, and reduced quality of life. More than 54 million US adults1 have arthritis, half of whom are working age2; and 78 million are projected to have it by 20403. Arthritis is significant, not only because it limits physical function and quality of life, but because it commonly co-occurs with other chronic conditions that are leading causes of death, such as heart disease, diabetes, and obesity, and can interfere with management of these conditions through its effects on limiting physical activity (PA)2.
 
People with arthritis face barriers to PA such as fear of worsening arthritis pain and progression2. However, arthritis and its limitations can be managed effectively, and symptoms improved through routine PA and participation in self-management education (SME) programs2. Low-cost, arthritis-appropriate, evidence-based interventions (AAEBIs) shown to decrease arthritis pain and/or disability and improve quality of life are available in geographic pockets across the US but are still underused by people who can benefit from them2. Lack of awareness about AAEBIs, their benefits, and how to access them remain a challenge and a barrier to participation in these programs. More AAEBI offerings are needed, with greater geographic dispersion; and greater awareness to increase participation in them.
 
This NOFO will leverage and expand existing systems, technologies and networks with national reach and/or access into large segments of the adult population to sustainably increase awareness and availability of and participation in AAEBIs. It will also support technical assistance to state health departments and provision of arthritis-specific consumer health information to the public. Further, it will facilitate collaborative action to address osteoarthritis (OA) and address health equity and social determinants affecting AAEBI awareness and access and adoption of effective self-management behaviors. Lastly, it will support development of a national strategy targeted at healthcare providers to complement pharmacological treatments by specifically emphasizing adjunct self-management and physical activity approaches. The NOFO goals are to enhance the health, wellness, and quality of life of adults with arthritis and improve arthritis management and health outcomes.
 
References:

Barbour KE, Helmick CG, Boring M, Brady TJ. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013-2015. MMWR 2017;66(9):246-253.
Barbour, K. E., Helmick, C. G., Boring, M., & Brady, T. J. (2017). Vital signs: prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013–2015. MMWR 2017;66(9):246.
Hootman JM, Helmick CG, Barbour KE, Theis KA, Boring MA. Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015-2040. Arthritis Rheumatol. 2016;68(7):1582-7.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Michele Mercier
zaf5@cdc.gov
Email:zaf5@cdc.gov

DISPLAYING: Synopsis 21

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-DP21-2106
Funding Opportunity Title: Advancing Arthritis Public Health Priorities through National Organizations
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 7
Assistance Listings: 93.945 — Assistance Programs for Chronic Disease Prevention and Control
Cost Sharing or Matching Requirement: No
Version: Synopsis 21
Posted Date: Jan 14, 2021
Last Updated Date: Aug 12, 2021
Original Closing Date for Applications:
Current Closing Date for Applications: Apr 05, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Aug 14, 2021
Estimated Total Program Funding: $10,185,595
Award Ceiling: $1,000,000
Award Floor: $150,000

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
State governments
For profit organizations other than small businesses
City or township governments
Independent school districts
Native American tribal governments (Federally recognized)
Private institutions of higher education
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Small businesses
County governments
Special district governments
Additional Information on Eligibility: This NOFO has two Components. Component 1 is focused on Building Capacity & Scaling Up whereas Component 2 is focused on Innovation. Applicants may apply for either or both Component 1 or Component 2. Component 1 applicants must select only one of the four options (A, B, C or D). Applicants must identify the Component they are applying for in the title of their application submission. If not clearly identified, the application will be considered non-responsive and will not be entered into the review process. A separate application must be submitted for each Component if applying for more than one.

Applicants are required to submit a budget within the range noted for each Component and corresponding strategy. If the proposed budget exceeds the Component and Strategy funding range, the application will be considered non-responsive and will not be entered into the review process.

Component 1 Funding Range:

Strategy A – $300K-$500K
Strategy B – $150K-$250K
Strategy C – $400K-$500K
Strategy D – $200K-$300K

Component 2 Funding Range – $300K-$500K

Additional Information

Agency Name: Centers for Disease Control – NCCDPHP
Description: The CDC Arthritis Program is announcing a new, FY21 non-research NOFO designed to improve health and quality of life for people with arthritis. Arthritis is an oft overlooked, leading contributor to chronic disease burden and a top cause of morbidity, work limitations, and reduced quality of life. More than 54 million US adults1 have arthritis, half of whom are working age2; and 78 million are projected to have it by 20403. Arthritis is significant, not only because it limits physical function and quality of life, but because it commonly co-occurs with other chronic conditions that are leading causes of death, such as heart disease, diabetes, and obesity, and can interfere with management of these conditions through its effects on limiting physical activity (PA)2.
 
People with arthritis face barriers to PA such as fear of worsening arthritis pain and progression2. However, arthritis and its limitations can be managed effectively, and symptoms improved through routine PA and participation in self-management education (SME) programs2. Low-cost, arthritis-appropriate, evidence-based interventions (AAEBIs) shown to decrease arthritis pain and/or disability and improve quality of life are available in geographic pockets across the US but are still underused by people who can benefit from them2. Lack of awareness about AAEBIs, their benefits, and how to access them remain a challenge and a barrier to participation in these programs. More AAEBI offerings are needed, with greater geographic dispersion; and greater awareness to increase participation in them.
 
This NOFO will leverage and expand existing systems, technologies and networks with national reach and/or access into large segments of the adult population to sustainably increase awareness and availability of and participation in AAEBIs. It will also support technical assistance to state health departments and provision of arthritis-specific consumer health information to the public. Further, it will facilitate collaborative action to address osteoarthritis (OA) and address health equity and social determinants affecting AAEBI awareness and access and adoption of effective self-management behaviors. Lastly, it will support development of a national strategy targeted at healthcare providers to complement pharmacological treatments by specifically emphasizing adjunct self-management and physical activity approaches. The NOFO goals are to enhance the health, wellness, and quality of life of adults with arthritis and improve arthritis management and health outcomes.
 
References:

Barbour KE, Helmick CG, Boring M, Brady TJ. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013-2015. MMWR 2017;66(9):246-253.
Barbour, K. E., Helmick, C. G., Boring, M., & Brady, T. J. (2017). Vital signs: prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013–2015. MMWR 2017;66(9):246.
Hootman JM, Helmick CG, Barbour KE, Theis KA, Boring MA. Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015-2040. Arthritis Rheumatol. 2016;68(7):1582-7.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Michele Mercier
zaf5@cdc.gov
Email:zaf5@cdc.gov

DISPLAYING: Synopsis 20

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-DP21-2106
Funding Opportunity Title: Advancing Arthritis Public Health Priorities through National Organizations
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 7
Assistance Listings: 93.945 — Assistance Programs for Chronic Disease Prevention and Control
Cost Sharing or Matching Requirement: No
Version: Synopsis 20
Posted Date: Jan 14, 2021
Last Updated Date: Aug 12, 2021
Original Closing Date for Applications:
Current Closing Date for Applications: Apr 05, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Aug 14, 2021
Estimated Total Program Funding: $10,185,595
Award Ceiling: $1,000,000
Award Floor: $150,000

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
State governments
For profit organizations other than small businesses
City or township governments
Independent school districts
Native American tribal governments (Federally recognized)
Private institutions of higher education
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Small businesses
County governments
Special district governments
Additional Information on Eligibility: This NOFO has two Components. Component 1 is focused on Building Capacity & Scaling Up whereas Component 2 is focused on Innovation. Applicants may apply for either or both Component 1 or Component 2. Component 1 applicants must select only one of the four options (A, B, C or D). Applicants must identify the Component they are applying for in the title of their application submission. If not clearly identified, the application will be considered non-responsive and will not be entered into the review process. A separate application must be submitted for each Component if applying for more than one.

Applicants are required to submit a budget within the range noted for each Component and corresponding strategy. If the proposed budget exceeds the Component and Strategy funding range, the application will be considered non-responsive and will not be entered into the review process.

Component 1 Funding Range:

Strategy A – $300K-$500K
Strategy B – $150K-$250K
Strategy C – $400K-$500K
Strategy D – $200K-$300K

Component 2 Funding Range – $300K-$500K

Additional Information

Agency Name: Centers for Disease Control – NCCDPHP
Description: The CDC Arthritis Program is announcing a new, FY21 non-research NOFO designed to improve health and quality of life for people with arthritis. Arthritis is an oft overlooked, leading contributor to chronic disease burden and a top cause of morbidity, work limitations, and reduced quality of life. More than 54 million US adults1 have arthritis, half of whom are working age2; and 78 million are projected to have it by 20403. Arthritis is significant, not only because it limits physical function and quality of life, but because it commonly co-occurs with other chronic conditions that are leading causes of death, such as heart disease, diabetes, and obesity, and can interfere with management of these conditions through its effects on limiting physical activity (PA)2.
 
People with arthritis face barriers to PA such as fear of worsening arthritis pain and progression2. However, arthritis and its limitations can be managed effectively, and symptoms improved through routine PA and participation in self-management education (SME) programs2. Low-cost, arthritis-appropriate, evidence-based interventions (AAEBIs) shown to decrease arthritis pain and/or disability and improve quality of life are available in geographic pockets across the US but are still underused by people who can benefit from them2. Lack of awareness about AAEBIs, their benefits, and how to access them remain a challenge and a barrier to participation in these programs. More AAEBI offerings are needed, with greater geographic dispersion; and greater awareness to increase participation in them.
 
This NOFO will leverage and expand existing systems, technologies and networks with national reach and/or access into large segments of the adult population to sustainably increase awareness and availability of and participation in AAEBIs. It will also support technical assistance to state health departments and provision of arthritis-specific consumer health information to the public. Further, it will facilitate collaborative action to address osteoarthritis (OA) and address health equity and social determinants affecting AAEBI awareness and access and adoption of effective self-management behaviors. Lastly, it will support development of a national strategy targeted at healthcare providers to complement pharmacological treatments by specifically emphasizing adjunct self-management and physical activity approaches. The NOFO goals are to enhance the health, wellness, and quality of life of adults with arthritis and improve arthritis management and health outcomes.
 
References:

Barbour KE, Helmick CG, Boring M, Brady TJ. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013-2015. MMWR 2017;66(9):246-253.
Barbour, K. E., Helmick, C. G., Boring, M., & Brady, T. J. (2017). Vital signs: prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013–2015. MMWR 2017;66(9):246.
Hootman JM, Helmick CG, Barbour KE, Theis KA, Boring MA. Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015-2040. Arthritis Rheumatol. 2016;68(7):1582-7.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Michele Mercier
zaf5@cdc.gov
Email:zaf5@cdc.gov

DISPLAYING: Synopsis 19

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-DP21-2106
Funding Opportunity Title: Advancing Arthritis Public Health Priorities through National Organizations
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 7
Assistance Listings: 93.945 — Assistance Programs for Chronic Disease Prevention and Control
Cost Sharing or Matching Requirement: No
Version: Synopsis 19
Posted Date: Jan 14, 2021
Last Updated Date: Aug 12, 2021
Original Closing Date for Applications:
Current Closing Date for Applications: Apr 05, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Aug 14, 2021
Estimated Total Program Funding: $10,185,595
Award Ceiling: $1,000,000
Award Floor: $150,000

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
State governments
For profit organizations other than small businesses
City or township governments
Independent school districts
Native American tribal governments (Federally recognized)
Private institutions of higher education
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Small businesses
County governments
Special district governments
Additional Information on Eligibility: This NOFO has two Components. Component 1 is focused on Building Capacity & Scaling Up whereas Component 2 is focused on Innovation. Applicants may apply for either or both Component 1 or Component 2. Component 1 applicants must select only one of the four options (A, B, C or D). Applicants must identify the Component they are applying for in the title of their application submission. If not clearly identified, the application will be considered non-responsive and will not be entered into the review process. A separate application must be submitted for each Component if applying for more than one.

Applicants are required to submit a budget within the range noted for each Component and corresponding strategy. If the proposed budget exceeds the Component and Strategy funding range, the application will be considered non-responsive and will not be entered into the review process.

Component 1 Funding Range:

Strategy A – $300K-$500K
Strategy B – $150K-$250K
Strategy C – $400K-$500K
Strategy D – $200K-$300K

Component 2 Funding Range – $300K-$500K

Additional Information

Agency Name: Centers for Disease Control – NCCDPHP
Description: The CDC Arthritis Program is announcing a new, FY21 non-research NOFO designed to improve health and quality of life for people with arthritis. Arthritis is an oft overlooked, leading contributor to chronic disease burden and a top cause of morbidity, work limitations, and reduced quality of life. More than 54 million US adults1 have arthritis, half of whom are working age2; and 78 million are projected to have it by 20403. Arthritis is significant, not only because it limits physical function and quality of life, but because it commonly co-occurs with other chronic conditions that are leading causes of death, such as heart disease, diabetes, and obesity, and can interfere with management of these conditions through its effects on limiting physical activity (PA)2.
 
People with arthritis face barriers to PA such as fear of worsening arthritis pain and progression2. However, arthritis and its limitations can be managed effectively, and symptoms improved through routine PA and participation in self-management education (SME) programs2. Low-cost, arthritis-appropriate, evidence-based interventions (AAEBIs) shown to decrease arthritis pain and/or disability and improve quality of life are available in geographic pockets across the US but are still underused by people who can benefit from them2. Lack of awareness about AAEBIs, their benefits, and how to access them remain a challenge and a barrier to participation in these programs. More AAEBI offerings are needed, with greater geographic dispersion; and greater awareness to increase participation in them.
 
This NOFO will leverage and expand existing systems, technologies and networks with national reach and/or access into large segments of the adult population to sustainably increase awareness and availability of and participation in AAEBIs. It will also support technical assistance to state health departments and provision of arthritis-specific consumer health information to the public. Further, it will facilitate collaborative action to address osteoarthritis (OA) and address health equity and social determinants affecting AAEBI awareness and access and adoption of effective self-management behaviors. Lastly, it will support development of a national strategy targeted at healthcare providers to complement pharmacological treatments by specifically emphasizing adjunct self-management and physical activity approaches. The NOFO goals are to enhance the health, wellness, and quality of life of adults with arthritis and improve arthritis management and health outcomes.
 
References:

Barbour KE, Helmick CG, Boring M, Brady TJ. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013-2015. MMWR 2017;66(9):246-253.
Barbour, K. E., Helmick, C. G., Boring, M., & Brady, T. J. (2017). Vital signs: prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013–2015. MMWR 2017;66(9):246.
Hootman JM, Helmick CG, Barbour KE, Theis KA, Boring MA. Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015-2040. Arthritis Rheumatol. 2016;68(7):1582-7.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Michele Mercier
zaf5@cdc.gov
Email:zaf5@cdc.gov

DISPLAYING: Synopsis 18

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-DP21-2106
Funding Opportunity Title: Advancing Arthritis Public Health Priorities through National Organizations
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 7
Assistance Listings: 93.945 — Assistance Programs for Chronic Disease Prevention and Control
Cost Sharing or Matching Requirement: No
Version: Synopsis 18
Posted Date: Jan 14, 2021
Last Updated Date: Aug 12, 2021
Original Closing Date for Applications:
Current Closing Date for Applications: Apr 05, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Aug 14, 2021
Estimated Total Program Funding: $10,185,595
Award Ceiling: $1,000,000
Award Floor: $150,000

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
State governments
For profit organizations other than small businesses
City or township governments
Independent school districts
Native American tribal governments (Federally recognized)
Private institutions of higher education
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Small businesses
County governments
Special district governments
Additional Information on Eligibility: This NOFO has two Components. Component 1 is focused on Building Capacity & Scaling Up whereas Component 2 is focused on Innovation. Applicants may apply for either or both Component 1 or Component 2. Component 1 applicants must select only one of the four options (A, B, C or D). Applicants must identify the Component they are applying for in the title of their application submission. If not clearly identified, the application will be considered non-responsive and will not be entered into the review process. A separate application must be submitted for each Component if applying for more than one.

Applicants are required to submit a budget within the range noted for each Component and corresponding strategy. If the proposed budget exceeds the Component and Strategy funding range, the application will be considered non-responsive and will not be entered into the review process.

Component 1 Funding Range:

Strategy A – $300K-$500K
Strategy B – $150K-$250K
Strategy C – $400K-$500K
Strategy D – $200K-$300K

Component 2 Funding Range – $300K-$500K

Additional Information

Agency Name: Centers for Disease Control – NCCDPHP
Description: The CDC Arthritis Program is announcing a new, FY21 non-research NOFO designed to improve health and quality of life for people with arthritis. Arthritis is an oft overlooked, leading contributor to chronic disease burden and a top cause of morbidity, work limitations, and reduced quality of life. More than 54 million US adults1 have arthritis, half of whom are working age2; and 78 million are projected to have it by 20403. Arthritis is significant, not only because it limits physical function and quality of life, but because it commonly co-occurs with other chronic conditions that are leading causes of death, such as heart disease, diabetes, and obesity, and can interfere with management of these conditions through its effects on limiting physical activity (PA)2.
 
People with arthritis face barriers to PA such as fear of worsening arthritis pain and progression2. However, arthritis and its limitations can be managed effectively, and symptoms improved through routine PA and participation in self-management education (SME) programs2. Low-cost, arthritis-appropriate, evidence-based interventions (AAEBIs) shown to decrease arthritis pain and/or disability and improve quality of life are available in geographic pockets across the US but are still underused by people who can benefit from them2. Lack of awareness about AAEBIs, their benefits, and how to access them remain a challenge and a barrier to participation in these programs. More AAEBI offerings are needed, with greater geographic dispersion; and greater awareness to increase participation in them.
 
This NOFO will leverage and expand existing systems, technologies and networks with national reach and/or access into large segments of the adult population to sustainably increase awareness and availability of and participation in AAEBIs. It will also support technical assistance to state health departments and provision of arthritis-specific consumer health information to the public. Further, it will facilitate collaborative action to address osteoarthritis (OA) and address health equity and social determinants affecting AAEBI awareness and access and adoption of effective self-management behaviors. Lastly, it will support development of a national strategy targeted at healthcare providers to complement pharmacological treatments by specifically emphasizing adjunct self-management and physical activity approaches. The NOFO goals are to enhance the health, wellness, and quality of life of adults with arthritis and improve arthritis management and health outcomes.
 
References:

Barbour KE, Helmick CG, Boring M, Brady TJ. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013-2015. MMWR 2017;66(9):246-253.
Barbour, K. E., Helmick, C. G., Boring, M., & Brady, T. J. (2017). Vital signs: prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013–2015. MMWR 2017;66(9):246.
Hootman JM, Helmick CG, Barbour KE, Theis KA, Boring MA. Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015-2040. Arthritis Rheumatol. 2016;68(7):1582-7.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Michele Mercier
zaf5@cdc.gov
Email:zaf5@cdc.gov

DISPLAYING: Synopsis 17

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-DP21-2106
Funding Opportunity Title: Advancing Arthritis Public Health Priorities through National Organizations
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 7
Assistance Listings: 93.945 — Assistance Programs for Chronic Disease Prevention and Control
Cost Sharing or Matching Requirement: No
Version: Synopsis 17
Posted Date: Jan 14, 2021
Last Updated Date: Aug 12, 2021
Original Closing Date for Applications:
Current Closing Date for Applications: Apr 05, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Aug 14, 2021
Estimated Total Program Funding: $10,185,595
Award Ceiling: $1,000,000
Award Floor: $150,000

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
State governments
For profit organizations other than small businesses
City or township governments
Independent school districts
Native American tribal governments (Federally recognized)
Private institutions of higher education
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Small businesses
County governments
Special district governments
Additional Information on Eligibility: This NOFO has two Components. Component 1 is focused on Building Capacity & Scaling Up whereas Component 2 is focused on Innovation. Applicants may apply for either or both Component 1 or Component 2. Component 1 applicants must select only one of the four options (A, B, C or D). Applicants must identify the Component they are applying for in the title of their application submission. If not clearly identified, the application will be considered non-responsive and will not be entered into the review process. A separate application must be submitted for each Component if applying for more than one.

Applicants are required to submit a budget within the range noted for each Component and corresponding strategy. If the proposed budget exceeds the Component and Strategy funding range, the application will be considered non-responsive and will not be entered into the review process.

Component 1 Funding Range:

Strategy A – $300K-$500K
Strategy B – $150K-$250K
Strategy C – $400K-$500K
Strategy D – $200K-$300K

Component 2 Funding Range – $300K-$500K

Additional Information

Agency Name: Centers for Disease Control – NCCDPHP
Description: The CDC Arthritis Program is announcing a new, FY21 non-research NOFO designed to improve health and quality of life for people with arthritis. Arthritis is an oft overlooked, leading contributor to chronic disease burden and a top cause of morbidity, work limitations, and reduced quality of life. More than 54 million US adults1 have arthritis, half of whom are working age2; and 78 million are projected to have it by 20403. Arthritis is significant, not only because it limits physical function and quality of life, but because it commonly co-occurs with other chronic conditions that are leading causes of death, such as heart disease, diabetes, and obesity, and can interfere with management of these conditions through its effects on limiting physical activity (PA)2.
 
People with arthritis face barriers to PA such as fear of worsening arthritis pain and progression2. However, arthritis and its limitations can be managed effectively, and symptoms improved through routine PA and participation in self-management education (SME) programs2. Low-cost, arthritis-appropriate, evidence-based interventions (AAEBIs) shown to decrease arthritis pain and/or disability and improve quality of life are available in geographic pockets across the US but are still underused by people who can benefit from them2. Lack of awareness about AAEBIs, their benefits, and how to access them remain a challenge and a barrier to participation in these programs. More AAEBI offerings are needed, with greater geographic dispersion; and greater awareness to increase participation in them.
 
This NOFO will leverage and expand existing systems, technologies and networks with national reach and/or access into large segments of the adult population to sustainably increase awareness and availability of and participation in AAEBIs. It will also support technical assistance to state health departments and provision of arthritis-specific consumer health information to the public. Further, it will facilitate collaborative action to address osteoarthritis (OA) and address health equity and social determinants affecting AAEBI awareness and access and adoption of effective self-management behaviors. Lastly, it will support development of a national strategy targeted at healthcare providers to complement pharmacological treatments by specifically emphasizing adjunct self-management and physical activity approaches. The NOFO goals are to enhance the health, wellness, and quality of life of adults with arthritis and improve arthritis management and health outcomes.
 
References:

Barbour KE, Helmick CG, Boring M, Brady TJ. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013-2015. MMWR 2017;66(9):246-253.
Barbour, K. E., Helmick, C. G., Boring, M., & Brady, T. J. (2017). Vital signs: prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013–2015. MMWR 2017;66(9):246.
Hootman JM, Helmick CG, Barbour KE, Theis KA, Boring MA. Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015-2040. Arthritis Rheumatol. 2016;68(7):1582-7.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Michele Mercier
zaf5@cdc.gov
Email:zaf5@cdc.gov

DISPLAYING: Synopsis 16

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-DP21-2106
Funding Opportunity Title: Advancing Arthritis Public Health Priorities through National Organizations
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 7
Assistance Listings: 93.945 — Assistance Programs for Chronic Disease Prevention and Control
Cost Sharing or Matching Requirement: No
Version: Synopsis 16
Posted Date: Jan 14, 2021
Last Updated Date: Aug 12, 2021
Original Closing Date for Applications:
Current Closing Date for Applications: Apr 05, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Aug 14, 2021
Estimated Total Program Funding: $10,185,595
Award Ceiling: $1,000,000
Award Floor: $150,000

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
State governments
For profit organizations other than small businesses
City or township governments
Independent school districts
Native American tribal governments (Federally recognized)
Private institutions of higher education
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Small businesses
County governments
Special district governments
Additional Information on Eligibility: This NOFO has two Components. Component 1 is focused on Building Capacity & Scaling Up whereas Component 2 is focused on Innovation. Applicants may apply for either or both Component 1 or Component 2. Component 1 applicants must select only one of the four options (A, B, C or D). Applicants must identify the Component they are applying for in the title of their application submission. If not clearly identified, the application will be considered non-responsive and will not be entered into the review process. A separate application must be submitted for each Component if applying for more than one.

Applicants are required to submit a budget within the range noted for each Component and corresponding strategy. If the proposed budget exceeds the Component and Strategy funding range, the application will be considered non-responsive and will not be entered into the review process.

Component 1 Funding Range:

Strategy A – $300K-$500K
Strategy B – $150K-$250K
Strategy C – $400K-$500K
Strategy D – $200K-$300K

Component 2 Funding Range – $300K-$500K

Additional Information

Agency Name: Centers for Disease Control – NCCDPHP
Description: The CDC Arthritis Program is announcing a new, FY21 non-research NOFO designed to improve health and quality of life for people with arthritis. Arthritis is an oft overlooked, leading contributor to chronic disease burden and a top cause of morbidity, work limitations, and reduced quality of life. More than 54 million US adults1 have arthritis, half of whom are working age2; and 78 million are projected to have it by 20403. Arthritis is significant, not only because it limits physical function and quality of life, but because it commonly co-occurs with other chronic conditions that are leading causes of death, such as heart disease, diabetes, and obesity, and can interfere with management of these conditions through its effects on limiting physical activity (PA)2.
 
People with arthritis face barriers to PA such as fear of worsening arthritis pain and progression2. However, arthritis and its limitations can be managed effectively, and symptoms improved through routine PA and participation in self-management education (SME) programs2. Low-cost, arthritis-appropriate, evidence-based interventions (AAEBIs) shown to decrease arthritis pain and/or disability and improve quality of life are available in geographic pockets across the US but are still underused by people who can benefit from them2. Lack of awareness about AAEBIs, their benefits, and how to access them remain a challenge and a barrier to participation in these programs. More AAEBI offerings are needed, with greater geographic dispersion; and greater awareness to increase participation in them.
 
This NOFO will leverage and expand existing systems, technologies and networks with national reach and/or access into large segments of the adult population to sustainably increase awareness and availability of and participation in AAEBIs. It will also support technical assistance to state health departments and provision of arthritis-specific consumer health information to the public. Further, it will facilitate collaborative action to address osteoarthritis (OA) and address health equity and social determinants affecting AAEBI awareness and access and adoption of effective self-management behaviors. Lastly, it will support development of a national strategy targeted at healthcare providers to complement pharmacological treatments by specifically emphasizing adjunct self-management and physical activity approaches. The NOFO goals are to enhance the health, wellness, and quality of life of adults with arthritis and improve arthritis management and health outcomes.
 
References:

Barbour KE, Helmick CG, Boring M, Brady TJ. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013-2015. MMWR 2017;66(9):246-253.
Barbour, K. E., Helmick, C. G., Boring, M., & Brady, T. J. (2017). Vital signs: prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013–2015. MMWR 2017;66(9):246.
Hootman JM, Helmick CG, Barbour KE, Theis KA, Boring MA. Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015-2040. Arthritis Rheumatol. 2016;68(7):1582-7.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Michele Mercier
zaf5@cdc.gov
Email:zaf5@cdc.gov

DISPLAYING: Synopsis 15

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-DP21-2106
Funding Opportunity Title: Advancing Arthritis Public Health Priorities through National Organizations
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 7
Assistance Listings: 93.945 — Assistance Programs for Chronic Disease Prevention and Control
Cost Sharing or Matching Requirement: No
Version: Synopsis 15
Posted Date: Jan 14, 2021
Last Updated Date: Aug 12, 2021
Original Closing Date for Applications:
Current Closing Date for Applications: Apr 05, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Aug 14, 2021
Estimated Total Program Funding: $10,185,595
Award Ceiling: $1,000,000
Award Floor: $150,000

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
State governments
For profit organizations other than small businesses
City or township governments
Independent school districts
Native American tribal governments (Federally recognized)
Private institutions of higher education
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Small businesses
County governments
Special district governments
Additional Information on Eligibility: This NOFO has two Components. Component 1 is focused on Building Capacity & Scaling Up whereas Component 2 is focused on Innovation. Applicants may apply for either or both Component 1 or Component 2. Component 1 applicants must select only one of the four options (A, B, C or D). Applicants must identify the Component they are applying for in the title of their application submission. If not clearly identified, the application will be considered non-responsive and will not be entered into the review process. A separate application must be submitted for each Component if applying for more than one.

Applicants are required to submit a budget within the range noted for each Component and corresponding strategy. If the proposed budget exceeds the Component and Strategy funding range, the application will be considered non-responsive and will not be entered into the review process.

Component 1 Funding Range:

Strategy A – $300K-$500K
Strategy B – $150K-$250K
Strategy C – $400K-$500K
Strategy D – $200K-$300K

Component 2 Funding Range – $300K-$500K

Additional Information

Agency Name: Centers for Disease Control – NCCDPHP
Description: The CDC Arthritis Program is announcing a new, FY21 non-research NOFO designed to improve health and quality of life for people with arthritis. Arthritis is an oft overlooked, leading contributor to chronic disease burden and a top cause of morbidity, work limitations, and reduced quality of life. More than 54 million US adults1 have arthritis, half of whom are working age2; and 78 million are projected to have it by 20403. Arthritis is significant, not only because it limits physical function and quality of life, but because it commonly co-occurs with other chronic conditions that are leading causes of death, such as heart disease, diabetes, and obesity, and can interfere with management of these conditions through its effects on limiting physical activity (PA)2.
 
People with arthritis face barriers to PA such as fear of worsening arthritis pain and progression2. However, arthritis and its limitations can be managed effectively, and symptoms improved through routine PA and participation in self-management education (SME) programs2. Low-cost, arthritis-appropriate, evidence-based interventions (AAEBIs) shown to decrease arthritis pain and/or disability and improve quality of life are available in geographic pockets across the US but are still underused by people who can benefit from them2. Lack of awareness about AAEBIs, their benefits, and how to access them remain a challenge and a barrier to participation in these programs. More AAEBI offerings are needed, with greater geographic dispersion; and greater awareness to increase participation in them.
 
This NOFO will leverage and expand existing systems, technologies and networks with national reach and/or access into large segments of the adult population to sustainably increase awareness and availability of and participation in AAEBIs. It will also support technical assistance to state health departments and provision of arthritis-specific consumer health information to the public. Further, it will facilitate collaborative action to address osteoarthritis (OA) and address health equity and social determinants affecting AAEBI awareness and access and adoption of effective self-management behaviors. Lastly, it will support development of a national strategy targeted at healthcare providers to complement pharmacological treatments by specifically emphasizing adjunct self-management and physical activity approaches. The NOFO goals are to enhance the health, wellness, and quality of life of adults with arthritis and improve arthritis management and health outcomes.
 
References:

Barbour KE, Helmick CG, Boring M, Brady TJ. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013-2015. MMWR 2017;66(9):246-253.
Barbour, K. E., Helmick, C. G., Boring, M., & Brady, T. J. (2017). Vital signs: prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013–2015. MMWR 2017;66(9):246.
Hootman JM, Helmick CG, Barbour KE, Theis KA, Boring MA. Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015-2040. Arthritis Rheumatol. 2016;68(7):1582-7.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Michele Mercier
zaf5@cdc.gov
Email:zaf5@cdc.gov

DISPLAYING: Synopsis 14

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-DP21-2106
Funding Opportunity Title: Advancing Arthritis Public Health Priorities through National Organizations
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 7
Assistance Listings: 93.945 — Assistance Programs for Chronic Disease Prevention and Control
Cost Sharing or Matching Requirement: No
Version: Synopsis 14
Posted Date: Jan 14, 2021
Last Updated Date: Aug 12, 2021
Original Closing Date for Applications:
Current Closing Date for Applications: Apr 05, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Aug 02, 2021
Estimated Total Program Funding: $10,185,595
Award Ceiling: $1,000,000
Award Floor: $150,000

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
State governments
For profit organizations other than small businesses
City or township governments
Independent school districts
Native American tribal governments (Federally recognized)
Private institutions of higher education
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Small businesses
County governments
Special district governments
Additional Information on Eligibility: This NOFO has two Components. Component 1 is focused on Building Capacity & Scaling Up whereas Component 2 is focused on Innovation. Applicants may apply for either or both Component 1 or Component 2. Component 1 applicants must select only one of the four options (A, B, C or D). Applicants must identify the Component they are applying for in the title of their application submission. If not clearly identified, the application will be considered non-responsive and will not be entered into the review process. A separate application must be submitted for each Component if applying for more than one.

Applicants are required to submit a budget within the range noted for each Component and corresponding strategy. If the proposed budget exceeds the Component and Strategy funding range, the application will be considered non-responsive and will not be entered into the review process.

Component 1 Funding Range:

Strategy A – $300K-$500K
Strategy B – $150K-$250K
Strategy C – $400K-$500K
Strategy D – $200K-$300K

Component 2 Funding Range – $300K-$500K

Additional Information

Agency Name: Centers for Disease Control – NCCDPHP
Description: The CDC Arthritis Program is announcing a new, FY21 non-research NOFO designed to improve health and quality of life for people with arthritis. Arthritis is an oft overlooked, leading contributor to chronic disease burden and a top cause of morbidity, work limitations, and reduced quality of life. More than 54 million US adults1 have arthritis, half of whom are working age2; and 78 million are projected to have it by 20403. Arthritis is significant, not only because it limits physical function and quality of life, but because it commonly co-occurs with other chronic conditions that are leading causes of death, such as heart disease, diabetes, and obesity, and can interfere with management of these conditions through its effects on limiting physical activity (PA)2.
 
People with arthritis face barriers to PA such as fear of worsening arthritis pain and progression2. However, arthritis and its limitations can be managed effectively, and symptoms improved through routine PA and participation in self-management education (SME) programs2. Low-cost, arthritis-appropriate, evidence-based interventions (AAEBIs) shown to decrease arthritis pain and/or disability and improve quality of life are available in geographic pockets across the US but are still underused by people who can benefit from them2. Lack of awareness about AAEBIs, their benefits, and how to access them remain a challenge and a barrier to participation in these programs. More AAEBI offerings are needed, with greater geographic dispersion; and greater awareness to increase participation in them.
 
This NOFO will leverage and expand existing systems, technologies and networks with national reach and/or access into large segments of the adult population to sustainably increase awareness and availability of and participation in AAEBIs. It will also support technical assistance to state health departments and provision of arthritis-specific consumer health information to the public. Further, it will facilitate collaborative action to address osteoarthritis (OA) and address health equity and social determinants affecting AAEBI awareness and access and adoption of effective self-management behaviors. Lastly, it will support development of a national strategy targeted at healthcare providers to complement pharmacological treatments by specifically emphasizing adjunct self-management and physical activity approaches. The NOFO goals are to enhance the health, wellness, and quality of life of adults with arthritis and improve arthritis management and health outcomes.
 
References:

Barbour KE, Helmick CG, Boring M, Brady TJ. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013-2015. MMWR 2017;66(9):246-253.
Barbour, K. E., Helmick, C. G., Boring, M., & Brady, T. J. (2017). Vital signs: prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013–2015. MMWR 2017;66(9):246.
Hootman JM, Helmick CG, Barbour KE, Theis KA, Boring MA. Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015-2040. Arthritis Rheumatol. 2016;68(7):1582-7.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Michele Mercier
zaf5@cdc.gov
Email:zaf5@cdc.gov

DISPLAYING: Synopsis 13

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-DP21-2106
Funding Opportunity Title: Advancing Arthritis Public Health Priorities through National Organizations
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 7
Assistance Listings: 93.945 — Assistance Programs for Chronic Disease Prevention and Control
Cost Sharing or Matching Requirement: No
Version: Synopsis 13
Posted Date: Jan 14, 2021
Last Updated Date: Jul 30, 2021
Original Closing Date for Applications:
Current Closing Date for Applications: Apr 05, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Jul 30, 2021
Estimated Total Program Funding: $10,185,595
Award Ceiling: $1,000,000
Award Floor: $150,000

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
State governments
For profit organizations other than small businesses
City or township governments
Independent school districts
Native American tribal governments (Federally recognized)
Private institutions of higher education
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Small businesses
County governments
Special district governments
Additional Information on Eligibility: This NOFO has two Components. Component 1 is focused on Building Capacity & Scaling Up whereas Component 2 is focused on Innovation. Applicants may apply for either or both Component 1 or Component 2. Component 1 applicants must select only one of the four options (A, B, C or D). Applicants must identify the Component they are applying for in the title of their application submission. If not clearly identified, the application will be considered non-responsive and will not be entered into the review process. A separate application must be submitted for each Component if applying for more than one.

Applicants are required to submit a budget within the range noted for each Component and corresponding strategy. If the proposed budget exceeds the Component and Strategy funding range, the application will be considered non-responsive and will not be entered into the review process.

Component 1 Funding Range:

Strategy A – $300K-$500K
Strategy B – $150K-$250K
Strategy C – $400K-$500K
Strategy D – $200K-$300K

Component 2 Funding Range – $300K-$500K

Additional Information

Agency Name: Centers for Disease Control – NCCDPHP
Description: The CDC Arthritis Program is announcing a new, FY21 non-research NOFO designed to improve health and quality of life for people with arthritis. Arthritis is an oft overlooked, leading contributor to chronic disease burden and a top cause of morbidity, work limitations, and reduced quality of life. More than 54 million US adults1 have arthritis, half of whom are working age2; and 78 million are projected to have it by 20403. Arthritis is significant, not only because it limits physical function and quality of life, but because it commonly co-occurs with other chronic conditions that are leading causes of death, such as heart disease, diabetes, and obesity, and can interfere with management of these conditions through its effects on limiting physical activity (PA)2.
 
People with arthritis face barriers to PA such as fear of worsening arthritis pain and progression2. However, arthritis and its limitations can be managed effectively, and symptoms improved through routine PA and participation in self-management education (SME) programs2. Low-cost, arthritis-appropriate, evidence-based interventions (AAEBIs) shown to decrease arthritis pain and/or disability and improve quality of life are available in geographic pockets across the US but are still underused by people who can benefit from them2. Lack of awareness about AAEBIs, their benefits, and how to access them remain a challenge and a barrier to participation in these programs. More AAEBI offerings are needed, with greater geographic dispersion; and greater awareness to increase participation in them.
 
This NOFO will leverage and expand existing systems, technologies and networks with national reach and/or access into large segments of the adult population to sustainably increase awareness and availability of and participation in AAEBIs. It will also support technical assistance to state health departments and provision of arthritis-specific consumer health information to the public. Further, it will facilitate collaborative action to address osteoarthritis (OA) and address health equity and social determinants affecting AAEBI awareness and access and adoption of effective self-management behaviors. Lastly, it will support development of a national strategy targeted at healthcare providers to complement pharmacological treatments by specifically emphasizing adjunct self-management and physical activity approaches. The NOFO goals are to enhance the health, wellness, and quality of life of adults with arthritis and improve arthritis management and health outcomes.
 
References:

Barbour KE, Helmick CG, Boring M, Brady TJ. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013-2015. MMWR 2017;66(9):246-253.
Barbour, K. E., Helmick, C. G., Boring, M., & Brady, T. J. (2017). Vital signs: prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013–2015. MMWR 2017;66(9):246.
Hootman JM, Helmick CG, Barbour KE, Theis KA, Boring MA. Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015-2040. Arthritis Rheumatol. 2016;68(7):1582-7.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Michele Mercier
zaf5@cdc.gov
Email:zaf5@cdc.gov

DISPLAYING: Synopsis 12

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-DP21-2106
Funding Opportunity Title: Advancing Arthritis Public Health Priorities through National Organizations
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 7
Assistance Listings: 93.945 — Assistance Programs for Chronic Disease Prevention and Control
Cost Sharing or Matching Requirement: No
Version: Synopsis 12
Posted Date: Jan 14, 2021
Last Updated Date: Jul 30, 2021
Original Closing Date for Applications:
Current Closing Date for Applications: Apr 05, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Jul 30, 2021
Estimated Total Program Funding: $10,185,595
Award Ceiling: $1,000,000
Award Floor: $150,000

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
State governments
For profit organizations other than small businesses
City or township governments
Independent school districts
Native American tribal governments (Federally recognized)
Private institutions of higher education
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Small businesses
County governments
Special district governments
Additional Information on Eligibility: This NOFO has two Components. Component 1 is focused on Building Capacity & Scaling Up whereas Component 2 is focused on Innovation. Applicants may apply for either or both Component 1 or Component 2. Component 1 applicants must select only one of the four options (A, B, C or D). Applicants must identify the Component they are applying for in the title of their application submission. If not clearly identified, the application will be considered non-responsive and will not be entered into the review process. A separate application must be submitted for each Component if applying for more than one.

Applicants are required to submit a budget within the range noted for each Component and corresponding strategy. If the proposed budget exceeds the Component and Strategy funding range, the application will be considered non-responsive and will not be entered into the review process.

Component 1 Funding Range:

Strategy A – $300K-$500K
Strategy B – $150K-$250K
Strategy C – $400K-$500K
Strategy D – $200K-$300K

Component 2 Funding Range – $300K-$500K

Additional Information

Agency Name: Centers for Disease Control – NCCDPHP
Description: The CDC Arthritis Program is announcing a new, FY21 non-research NOFO designed to improve health and quality of life for people with arthritis. Arthritis is an oft overlooked, leading contributor to chronic disease burden and a top cause of morbidity, work limitations, and reduced quality of life. More than 54 million US adults1 have arthritis, half of whom are working age2; and 78 million are projected to have it by 20403. Arthritis is significant, not only because it limits physical function and quality of life, but because it commonly co-occurs with other chronic conditions that are leading causes of death, such as heart disease, diabetes, and obesity, and can interfere with management of these conditions through its effects on limiting physical activity (PA)2.
 
People with arthritis face barriers to PA such as fear of worsening arthritis pain and progression2. However, arthritis and its limitations can be managed effectively, and symptoms improved through routine PA and participation in self-management education (SME) programs2. Low-cost, arthritis-appropriate, evidence-based interventions (AAEBIs) shown to decrease arthritis pain and/or disability and improve quality of life are available in geographic pockets across the US but are still underused by people who can benefit from them2. Lack of awareness about AAEBIs, their benefits, and how to access them remain a challenge and a barrier to participation in these programs. More AAEBI offerings are needed, with greater geographic dispersion; and greater awareness to increase participation in them.
 
This NOFO will leverage and expand existing systems, technologies and networks with national reach and/or access into large segments of the adult population to sustainably increase awareness and availability of and participation in AAEBIs. It will also support technical assistance to state health departments and provision of arthritis-specific consumer health information to the public. Further, it will facilitate collaborative action to address osteoarthritis (OA) and address health equity and social determinants affecting AAEBI awareness and access and adoption of effective self-management behaviors. Lastly, it will support development of a national strategy targeted at healthcare providers to complement pharmacological treatments by specifically emphasizing adjunct self-management and physical activity approaches. The NOFO goals are to enhance the health, wellness, and quality of life of adults with arthritis and improve arthritis management and health outcomes.
 
References:

Barbour KE, Helmick CG, Boring M, Brady TJ. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013-2015. MMWR 2017;66(9):246-253.
Barbour, K. E., Helmick, C. G., Boring, M., & Brady, T. J. (2017). Vital signs: prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013–2015. MMWR 2017;66(9):246.
Hootman JM, Helmick CG, Barbour KE, Theis KA, Boring MA. Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015-2040. Arthritis Rheumatol. 2016;68(7):1582-7.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Michele Mercier
zaf5@cdc.gov
Email:zaf5@cdc.gov

DISPLAYING: Synopsis 11

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-DP21-2106
Funding Opportunity Title: Advancing Arthritis Public Health Priorities through National Organizations
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 7
Assistance Listings: 93.945 — Assistance Programs for Chronic Disease Prevention and Control
Cost Sharing or Matching Requirement: No
Version: Synopsis 11
Posted Date: Jan 14, 2021
Last Updated Date: Jul 30, 2021
Original Closing Date for Applications:
Current Closing Date for Applications: Apr 05, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Jul 30, 2021
Estimated Total Program Funding: $10,185,595
Award Ceiling: $1,000,000
Award Floor: $150,000

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
State governments
For profit organizations other than small businesses
City or township governments
Independent school districts
Native American tribal governments (Federally recognized)
Private institutions of higher education
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Small businesses
County governments
Special district governments
Additional Information on Eligibility: This NOFO has two Components. Component 1 is focused on Building Capacity & Scaling Up whereas Component 2 is focused on Innovation. Applicants may apply for either or both Component 1 or Component 2. Component 1 applicants must select only one of the four options (A, B, C or D). Applicants must identify the Component they are applying for in the title of their application submission. If not clearly identified, the application will be considered non-responsive and will not be entered into the review process. A separate application must be submitted for each Component if applying for more than one.

Applicants are required to submit a budget within the range noted for each Component and corresponding strategy. If the proposed budget exceeds the Component and Strategy funding range, the application will be considered non-responsive and will not be entered into the review process.

Component 1 Funding Range:

Strategy A – $300K-$500K
Strategy B – $150K-$250K
Strategy C – $400K-$500K
Strategy D – $200K-$300K

Component 2 Funding Range – $300K-$500K

Additional Information

Agency Name: Centers for Disease Control – NCCDPHP
Description: The CDC Arthritis Program is announcing a new, FY21 non-research NOFO designed to improve health and quality of life for people with arthritis. Arthritis is an oft overlooked, leading contributor to chronic disease burden and a top cause of morbidity, work limitations, and reduced quality of life. More than 54 million US adults1 have arthritis, half of whom are working age2; and 78 million are projected to have it by 20403. Arthritis is significant, not only because it limits physical function and quality of life, but because it commonly co-occurs with other chronic conditions that are leading causes of death, such as heart disease, diabetes, and obesity, and can interfere with management of these conditions through its effects on limiting physical activity (PA)2.
 
People with arthritis face barriers to PA such as fear of worsening arthritis pain and progression2. However, arthritis and its limitations can be managed effectively, and symptoms improved through routine PA and participation in self-management education (SME) programs2. Low-cost, arthritis-appropriate, evidence-based interventions (AAEBIs) shown to decrease arthritis pain and/or disability and improve quality of life are available in geographic pockets across the US but are still underused by people who can benefit from them2. Lack of awareness about AAEBIs, their benefits, and how to access them remain a challenge and a barrier to participation in these programs. More AAEBI offerings are needed, with greater geographic dispersion; and greater awareness to increase participation in them.
 
This NOFO will leverage and expand existing systems, technologies and networks with national reach and/or access into large segments of the adult population to sustainably increase awareness and availability of and participation in AAEBIs. It will also support technical assistance to state health departments and provision of arthritis-specific consumer health information to the public. Further, it will facilitate collaborative action to address osteoarthritis (OA) and address health equity and social determinants affecting AAEBI awareness and access and adoption of effective self-management behaviors. Lastly, it will support development of a national strategy targeted at healthcare providers to complement pharmacological treatments by specifically emphasizing adjunct self-management and physical activity approaches. The NOFO goals are to enhance the health, wellness, and quality of life of adults with arthritis and improve arthritis management and health outcomes.
 
References:

Barbour KE, Helmick CG, Boring M, Brady TJ. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013-2015. MMWR 2017;66(9):246-253.
Barbour, K. E., Helmick, C. G., Boring, M., & Brady, T. J. (2017). Vital signs: prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013–2015. MMWR 2017;66(9):246.
Hootman JM, Helmick CG, Barbour KE, Theis KA, Boring MA. Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015-2040. Arthritis Rheumatol. 2016;68(7):1582-7.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Michele Mercier
zaf5@cdc.gov
Email:zaf5@cdc.gov

DISPLAYING: Synopsis 10

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-DP21-2106
Funding Opportunity Title: Advancing Arthritis Public Health Priorities through National Organizations
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 7
Assistance Listings: 93.945 — Assistance Programs for Chronic Disease Prevention and Control
Cost Sharing or Matching Requirement: No
Version: Synopsis 10
Posted Date: Jan 14, 2021
Last Updated Date: Jul 30, 2021
Original Closing Date for Applications:
Current Closing Date for Applications: Apr 05, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Jul 30, 2021
Estimated Total Program Funding: $10,185,595
Award Ceiling: $1,000,000
Award Floor: $150,000

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
State governments
For profit organizations other than small businesses
City or township governments
Independent school districts
Native American tribal governments (Federally recognized)
Private institutions of higher education
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Small businesses
County governments
Special district governments
Additional Information on Eligibility: This NOFO has two Components. Component 1 is focused on Building Capacity & Scaling Up whereas Component 2 is focused on Innovation. Applicants may apply for either or both Component 1 or Component 2. Component 1 applicants must select only one of the four options (A, B, C or D). Applicants must identify the Component they are applying for in the title of their application submission. If not clearly identified, the application will be considered non-responsive and will not be entered into the review process. A separate application must be submitted for each Component if applying for more than one.

Applicants are required to submit a budget within the range noted for each Component and corresponding strategy. If the proposed budget exceeds the Component and Strategy funding range, the application will be considered non-responsive and will not be entered into the review process.

Component 1 Funding Range:

Strategy A – $300K-$500K
Strategy B – $150K-$250K
Strategy C – $400K-$500K
Strategy D – $200K-$300K

Component 2 Funding Range – $300K-$500K

Additional Information

Agency Name: Centers for Disease Control – NCCDPHP
Description: The CDC Arthritis Program is announcing a new, FY21 non-research NOFO designed to improve health and quality of life for people with arthritis. Arthritis is an oft overlooked, leading contributor to chronic disease burden and a top cause of morbidity, work limitations, and reduced quality of life. More than 54 million US adults1 have arthritis, half of whom are working age2; and 78 million are projected to have it by 20403. Arthritis is significant, not only because it limits physical function and quality of life, but because it commonly co-occurs with other chronic conditions that are leading causes of death, such as heart disease, diabetes, and obesity, and can interfere with management of these conditions through its effects on limiting physical activity (PA)2.
 
People with arthritis face barriers to PA such as fear of worsening arthritis pain and progression2. However, arthritis and its limitations can be managed effectively, and symptoms improved through routine PA and participation in self-management education (SME) programs2. Low-cost, arthritis-appropriate, evidence-based interventions (AAEBIs) shown to decrease arthritis pain and/or disability and improve quality of life are available in geographic pockets across the US but are still underused by people who can benefit from them2. Lack of awareness about AAEBIs, their benefits, and how to access them remain a challenge and a barrier to participation in these programs. More AAEBI offerings are needed, with greater geographic dispersion; and greater awareness to increase participation in them.
 
This NOFO will leverage and expand existing systems, technologies and networks with national reach and/or access into large segments of the adult population to sustainably increase awareness and availability of and participation in AAEBIs. It will also support technical assistance to state health departments and provision of arthritis-specific consumer health information to the public. Further, it will facilitate collaborative action to address osteoarthritis (OA) and address health equity and social determinants affecting AAEBI awareness and access and adoption of effective self-management behaviors. Lastly, it will support development of a national strategy targeted at healthcare providers to complement pharmacological treatments by specifically emphasizing adjunct self-management and physical activity approaches. The NOFO goals are to enhance the health, wellness, and quality of life of adults with arthritis and improve arthritis management and health outcomes.
 
References:

Barbour KE, Helmick CG, Boring M, Brady TJ. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013-2015. MMWR 2017;66(9):246-253.
Barbour, K. E., Helmick, C. G., Boring, M., & Brady, T. J. (2017). Vital signs: prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013–2015. MMWR 2017;66(9):246.
Hootman JM, Helmick CG, Barbour KE, Theis KA, Boring MA. Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015-2040. Arthritis Rheumatol. 2016;68(7):1582-7.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Michele Mercier
zaf5@cdc.gov
Email:zaf5@cdc.gov

DISPLAYING: Synopsis 9

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-DP21-2106
Funding Opportunity Title: Advancing Arthritis Public Health Priorities through National Organizations
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 7
Assistance Listings: 93.945 — Assistance Programs for Chronic Disease Prevention and Control
Cost Sharing or Matching Requirement: No
Version: Synopsis 9
Posted Date: Jan 14, 2021
Last Updated Date: Jul 30, 2021
Original Closing Date for Applications:
Current Closing Date for Applications: Apr 05, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Jul 30, 2021
Estimated Total Program Funding: $10,185,595
Award Ceiling: $1,000,000
Award Floor: $150,000

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
State governments
For profit organizations other than small businesses
City or township governments
Independent school districts
Native American tribal governments (Federally recognized)
Private institutions of higher education
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Small businesses
County governments
Special district governments
Additional Information on Eligibility: This NOFO has two Components. Component 1 is focused on Building Capacity & Scaling Up whereas Component 2 is focused on Innovation. Applicants may apply for either or both Component 1 or Component 2. Component 1 applicants must select only one of the four options (A, B, C or D). Applicants must identify the Component they are applying for in the title of their application submission. If not clearly identified, the application will be considered non-responsive and will not be entered into the review process. A separate application must be submitted for each Component if applying for more than one.

Applicants are required to submit a budget within the range noted for each Component and corresponding strategy. If the proposed budget exceeds the Component and Strategy funding range, the application will be considered non-responsive and will not be entered into the review process.

Component 1 Funding Range:

Strategy A – $300K-$500K
Strategy B – $150K-$250K
Strategy C – $400K-$500K
Strategy D – $200K-$300K

Component 2 Funding Range – $300K-$500K

Additional Information

Agency Name: Centers for Disease Control – NCCDPHP
Description: The CDC Arthritis Program is announcing a new, FY21 non-research NOFO designed to improve health and quality of life for people with arthritis. Arthritis is an oft overlooked, leading contributor to chronic disease burden and a top cause of morbidity, work limitations, and reduced quality of life. More than 54 million US adults1 have arthritis, half of whom are working age2; and 78 million are projected to have it by 20403. Arthritis is significant, not only because it limits physical function and quality of life, but because it commonly co-occurs with other chronic conditions that are leading causes of death, such as heart disease, diabetes, and obesity, and can interfere with management of these conditions through its effects on limiting physical activity (PA)2.
 
People with arthritis face barriers to PA such as fear of worsening arthritis pain and progression2. However, arthritis and its limitations can be managed effectively, and symptoms improved through routine PA and participation in self-management education (SME) programs2. Low-cost, arthritis-appropriate, evidence-based interventions (AAEBIs) shown to decrease arthritis pain and/or disability and improve quality of life are available in geographic pockets across the US but are still underused by people who can benefit from them2. Lack of awareness about AAEBIs, their benefits, and how to access them remain a challenge and a barrier to participation in these programs. More AAEBI offerings are needed, with greater geographic dispersion; and greater awareness to increase participation in them.
 
This NOFO will leverage and expand existing systems, technologies and networks with national reach and/or access into large segments of the adult population to sustainably increase awareness and availability of and participation in AAEBIs. It will also support technical assistance to state health departments and provision of arthritis-specific consumer health information to the public. Further, it will facilitate collaborative action to address osteoarthritis (OA) and address health equity and social determinants affecting AAEBI awareness and access and adoption of effective self-management behaviors. Lastly, it will support development of a national strategy targeted at healthcare providers to complement pharmacological treatments by specifically emphasizing adjunct self-management and physical activity approaches. The NOFO goals are to enhance the health, wellness, and quality of life of adults with arthritis and improve arthritis management and health outcomes.
 
References:

Barbour KE, Helmick CG, Boring M, Brady TJ. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013-2015. MMWR 2017;66(9):246-253.
Barbour, K. E., Helmick, C. G., Boring, M., & Brady, T. J. (2017). Vital signs: prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013–2015. MMWR 2017;66(9):246.
Hootman JM, Helmick CG, Barbour KE, Theis KA, Boring MA. Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015-2040. Arthritis Rheumatol. 2016;68(7):1582-7.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Michele Mercier
zaf5@cdc.gov
Email:zaf5@cdc.gov

DISPLAYING: Synopsis 8

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-DP21-2106
Funding Opportunity Title: Advancing Arthritis Public Health Priorities through National Organizations
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 7
Assistance Listings: 93.945 — Assistance Programs for Chronic Disease Prevention and Control
Cost Sharing or Matching Requirement: No
Version: Synopsis 8
Posted Date: Jan 14, 2021
Last Updated Date: Jul 30, 2021
Original Closing Date for Applications:
Current Closing Date for Applications: Apr 05, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Jul 30, 2021
Estimated Total Program Funding: $10,185,595
Award Ceiling: $1,000,000
Award Floor: $150,000

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
State governments
For profit organizations other than small businesses
City or township governments
Independent school districts
Native American tribal governments (Federally recognized)
Private institutions of higher education
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Small businesses
County governments
Special district governments
Additional Information on Eligibility: This NOFO has two Components. Component 1 is focused on Building Capacity & Scaling Up whereas Component 2 is focused on Innovation. Applicants may apply for either or both Component 1 or Component 2. Component 1 applicants must select only one of the four options (A, B, C or D). Applicants must identify the Component they are applying for in the title of their application submission. If not clearly identified, the application will be considered non-responsive and will not be entered into the review process. A separate application must be submitted for each Component if applying for more than one.

Applicants are required to submit a budget within the range noted for each Component and corresponding strategy. If the proposed budget exceeds the Component and Strategy funding range, the application will be considered non-responsive and will not be entered into the review process.

Component 1 Funding Range:

Strategy A – $300K-$500K
Strategy B – $150K-$250K
Strategy C – $400K-$500K
Strategy D – $200K-$300K

Component 2 Funding Range – $300K-$500K

Additional Information

Agency Name: Centers for Disease Control – NCCDPHP
Description: The CDC Arthritis Program is announcing a new, FY21 non-research NOFO designed to improve health and quality of life for people with arthritis. Arthritis is an oft overlooked, leading contributor to chronic disease burden and a top cause of morbidity, work limitations, and reduced quality of life. More than 54 million US adults1 have arthritis, half of whom are working age2; and 78 million are projected to have it by 20403. Arthritis is significant, not only because it limits physical function and quality of life, but because it commonly co-occurs with other chronic conditions that are leading causes of death, such as heart disease, diabetes, and obesity, and can interfere with management of these conditions through its effects on limiting physical activity (PA)2.
 
People with arthritis face barriers to PA such as fear of worsening arthritis pain and progression2. However, arthritis and its limitations can be managed effectively, and symptoms improved through routine PA and participation in self-management education (SME) programs2. Low-cost, arthritis-appropriate, evidence-based interventions (AAEBIs) shown to decrease arthritis pain and/or disability and improve quality of life are available in geographic pockets across the US but are still underused by people who can benefit from them2. Lack of awareness about AAEBIs, their benefits, and how to access them remain a challenge and a barrier to participation in these programs. More AAEBI offerings are needed, with greater geographic dispersion; and greater awareness to increase participation in them.
 
This NOFO will leverage and expand existing systems, technologies and networks with national reach and/or access into large segments of the adult population to sustainably increase awareness and availability of and participation in AAEBIs. It will also support technical assistance to state health departments and provision of arthritis-specific consumer health information to the public. Further, it will facilitate collaborative action to address osteoarthritis (OA) and address health equity and social determinants affecting AAEBI awareness and access and adoption of effective self-management behaviors. Lastly, it will support development of a national strategy targeted at healthcare providers to complement pharmacological treatments by specifically emphasizing adjunct self-management and physical activity approaches. The NOFO goals are to enhance the health, wellness, and quality of life of adults with arthritis and improve arthritis management and health outcomes.
 
References:

Barbour KE, Helmick CG, Boring M, Brady TJ. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013-2015. MMWR 2017;66(9):246-253.
Barbour, K. E., Helmick, C. G., Boring, M., & Brady, T. J. (2017). Vital signs: prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013–2015. MMWR 2017;66(9):246.
Hootman JM, Helmick CG, Barbour KE, Theis KA, Boring MA. Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015-2040. Arthritis Rheumatol. 2016;68(7):1582-7.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Michele Mercier
zaf5@cdc.gov
Email:zaf5@cdc.gov

DISPLAYING: Synopsis 7

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-DP21-2106
Funding Opportunity Title: Advancing Arthritis Public Health Priorities through National Organizations
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 7
Assistance Listings: 93.945 — Assistance Programs for Chronic Disease Prevention and Control
Cost Sharing or Matching Requirement: No
Version: Synopsis 7
Posted Date: Jan 14, 2021
Last Updated Date: Jul 30, 2021
Original Closing Date for Applications:
Current Closing Date for Applications: Apr 05, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Jul 30, 2021
Estimated Total Program Funding: $10,185,595
Award Ceiling: $1,000,000
Award Floor: $150,000

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
State governments
For profit organizations other than small businesses
City or township governments
Independent school districts
Native American tribal governments (Federally recognized)
Private institutions of higher education
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Small businesses
County governments
Special district governments
Additional Information on Eligibility: This NOFO has two Components. Component 1 is focused on Building Capacity & Scaling Up whereas Component 2 is focused on Innovation. Applicants may apply for either or both Component 1 or Component 2. Component 1 applicants must select only one of the four options (A, B, C or D). Applicants must identify the Component they are applying for in the title of their application submission. If not clearly identified, the application will be considered non-responsive and will not be entered into the review process. A separate application must be submitted for each Component if applying for more than one.

Applicants are required to submit a budget within the range noted for each Component and corresponding strategy. If the proposed budget exceeds the Component and Strategy funding range, the application will be considered non-responsive and will not be entered into the review process.

Component 1 Funding Range:

Strategy A – $300K-$500K
Strategy B – $150K-$250K
Strategy C – $400K-$500K
Strategy D – $200K-$300K

Component 2 Funding Range – $300K-$500K

Additional Information

Agency Name: Centers for Disease Control – NCCDPHP
Description: The CDC Arthritis Program is announcing a new, FY21 non-research NOFO designed to improve health and quality of life for people with arthritis. Arthritis is an oft overlooked, leading contributor to chronic disease burden and a top cause of morbidity, work limitations, and reduced quality of life. More than 54 million US adults1 have arthritis, half of whom are working age2; and 78 million are projected to have it by 20403. Arthritis is significant, not only because it limits physical function and quality of life, but because it commonly co-occurs with other chronic conditions that are leading causes of death, such as heart disease, diabetes, and obesity, and can interfere with management of these conditions through its effects on limiting physical activity (PA)2.
 
People with arthritis face barriers to PA such as fear of worsening arthritis pain and progression2. However, arthritis and its limitations can be managed effectively, and symptoms improved through routine PA and participation in self-management education (SME) programs2. Low-cost, arthritis-appropriate, evidence-based interventions (AAEBIs) shown to decrease arthritis pain and/or disability and improve quality of life are available in geographic pockets across the US but are still underused by people who can benefit from them2. Lack of awareness about AAEBIs, their benefits, and how to access them remain a challenge and a barrier to participation in these programs. More AAEBI offerings are needed, with greater geographic dispersion; and greater awareness to increase participation in them.
 
This NOFO will leverage and expand existing systems, technologies and networks with national reach and/or access into large segments of the adult population to sustainably increase awareness and availability of and participation in AAEBIs. It will also support technical assistance to state health departments and provision of arthritis-specific consumer health information to the public. Further, it will facilitate collaborative action to address osteoarthritis (OA) and address health equity and social determinants affecting AAEBI awareness and access and adoption of effective self-management behaviors. Lastly, it will support development of a national strategy targeted at healthcare providers to complement pharmacological treatments by specifically emphasizing adjunct self-management and physical activity approaches. The NOFO goals are to enhance the health, wellness, and quality of life of adults with arthritis and improve arthritis management and health outcomes.
 
References:

Barbour KE, Helmick CG, Boring M, Brady TJ. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013-2015. MMWR 2017;66(9):246-253.
Barbour, K. E., Helmick, C. G., Boring, M., & Brady, T. J. (2017). Vital signs: prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013–2015. MMWR 2017;66(9):246.
Hootman JM, Helmick CG, Barbour KE, Theis KA, Boring MA. Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015-2040. Arthritis Rheumatol. 2016;68(7):1582-7.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Michele Mercier
zaf5@cdc.gov
Email:zaf5@cdc.gov

DISPLAYING: Synopsis 6

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-DP21-2106
Funding Opportunity Title: Advancing Arthritis Public Health Priorities through National Organizations
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 7
Assistance Listings: 93.945 — Assistance Programs for Chronic Disease Prevention and Control
Cost Sharing or Matching Requirement: No
Version: Synopsis 6
Posted Date: Jan 14, 2021
Last Updated Date: Jul 30, 2021
Original Closing Date for Applications:
Current Closing Date for Applications: Apr 05, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: Jul 30, 2021
Estimated Total Program Funding: $10,185,595
Award Ceiling: $1,000,000
Award Floor: $150,000

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
State governments
For profit organizations other than small businesses
City or township governments
Independent school districts
Native American tribal governments (Federally recognized)
Private institutions of higher education
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Small businesses
County governments
Special district governments
Additional Information on Eligibility: This NOFO has two Components. Component 1 is focused on Building Capacity & Scaling Up whereas Component 2 is focused on Innovation. Applicants may apply for either or both Component 1 or Component 2. Component 1 applicants must select only one of the four options (A, B, C or D). Applicants must identify the Component they are applying for in the title of their application submission. If not clearly identified, the application will be considered non-responsive and will not be entered into the review process. A separate application must be submitted for each Component if applying for more than one.

Applicants are required to submit a budget within the range noted for each Component and corresponding strategy. If the proposed budget exceeds the Component and Strategy funding range, the application will be considered non-responsive and will not be entered into the review process.

Component 1 Funding Range:

Strategy A – $300K-$500K
Strategy B – $150K-$250K
Strategy C – $400K-$500K
Strategy D – $200K-$300K

Component 2 Funding Range – $300K-$500K

Additional Information

Agency Name: Centers for Disease Control – NCCDPHP
Description: The CDC Arthritis Program is announcing a new, FY21 non-research NOFO designed to improve health and quality of life for people with arthritis. Arthritis is an oft overlooked, leading contributor to chronic disease burden and a top cause of morbidity, work limitations, and reduced quality of life. More than 54 million US adults1 have arthritis, half of whom are working age2; and 78 million are projected to have it by 20403. Arthritis is significant, not only because it limits physical function and quality of life, but because it commonly co-occurs with other chronic conditions that are leading causes of death, such as heart disease, diabetes, and obesity, and can interfere with management of these conditions through its effects on limiting physical activity (PA)2.
 
People with arthritis face barriers to PA such as fear of worsening arthritis pain and progression2. However, arthritis and its limitations can be managed effectively, and symptoms improved through routine PA and participation in self-management education (SME) programs2. Low-cost, arthritis-appropriate, evidence-based interventions (AAEBIs) shown to decrease arthritis pain and/or disability and improve quality of life are available in geographic pockets across the US but are still underused by people who can benefit from them2. Lack of awareness about AAEBIs, their benefits, and how to access them remain a challenge and a barrier to participation in these programs. More AAEBI offerings are needed, with greater geographic dispersion; and greater awareness to increase participation in them.
 
This NOFO will leverage and expand existing systems, technologies and networks with national reach and/or access into large segments of the adult population to sustainably increase awareness and availability of and participation in AAEBIs. It will also support technical assistance to state health departments and provision of arthritis-specific consumer health information to the public. Further, it will facilitate collaborative action to address osteoarthritis (OA) and address health equity and social determinants affecting AAEBI awareness and access and adoption of effective self-management behaviors. Lastly, it will support development of a national strategy targeted at healthcare providers to complement pharmacological treatments by specifically emphasizing adjunct self-management and physical activity approaches. The NOFO goals are to enhance the health, wellness, and quality of life of adults with arthritis and improve arthritis management and health outcomes.
 
References:

Barbour KE, Helmick CG, Boring M, Brady TJ. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013-2015. MMWR 2017;66(9):246-253.
Barbour, K. E., Helmick, C. G., Boring, M., & Brady, T. J. (2017). Vital signs: prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013–2015. MMWR 2017;66(9):246.
Hootman JM, Helmick CG, Barbour KE, Theis KA, Boring MA. Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015-2040. Arthritis Rheumatol. 2016;68(7):1582-7.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Michele Mercier
zaf5@cdc.gov
Email:zaf5@cdc.gov

DISPLAYING: Synopsis 5

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-DP21-2106
Funding Opportunity Title: Advancing Arthritis Public Health Priorities through National Organizations
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 7
Assistance Listings: 93.945 — Assistance Programs for Chronic Disease Prevention and Control
Cost Sharing or Matching Requirement: No
Version: Synopsis 5
Posted Date: Jan 14, 2021
Last Updated Date: Mar 24, 2021
Original Closing Date for Applications:
Current Closing Date for Applications: Apr 05, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: May 05, 2021
Estimated Total Program Funding: $10,185,595
Award Ceiling: $1,000,000
Award Floor: $150,000

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
State governments
For profit organizations other than small businesses
City or township governments
Independent school districts
Native American tribal governments (Federally recognized)
Private institutions of higher education
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Small businesses
County governments
Special district governments
Additional Information on Eligibility: This NOFO has two Components. Component 1 is focused on Building Capacity & Scaling Up whereas Component 2 is focused on Innovation. Applicants may apply for either or both Component 1 or Component 2. Component 1 applicants must select only one of the four options (A, B, C or D). Applicants must identify the Component they are applying for in the title of their application submission. If not clearly identified, the application will be considered non-responsive and will not be entered into the review process. A separate application must be submitted for each Component if applying for more than one.Applicants are required to submit a budget within the range noted for each Component and corresponding strategy. If the proposed budget exceeds the Component and Strategy funding range, the application will be considered non-responsive and will not be entered into the review process.Component 1 Funding Range: Strategy A – $300K-$500K Strategy B – $150K-$250K Strategy C – $400K-$500K Strategy D – $200K-$300KComponent 2 Funding Range – $300K-$500K

Additional Information

Agency Name: Centers for Disease Control – NCCDPHP
Description: The CDC Arthritis Program is announcing a new, FY21 non-research NOFO designed to improve health and quality of life for people with arthritis. Arthritis is an oft overlooked, leading contributor to chronic disease burden and a top cause of morbidity, work limitations, and reduced quality of life. More than 54 million US adults1 have arthritis, half of whom are working age2; and 78 million are projected to have it by 20403. Arthritis is significant, not only because it limits physical function and quality of life, but because it commonly co-occurs with other chronic conditions that are leading causes of death, such as heart disease, diabetes, and obesity, and can interfere with management of these conditions through its effects on limiting physical activity (PA)2. People with arthritis face barriers to PA such as fear of worsening arthritis pain and progression2. However, arthritis and its limitations can be managed effectively, and symptoms improved through routine PA and participation in self-management education (SME) programs2. Low-cost, arthritis-appropriate, evidence-based interventions (AAEBIs) shown to decrease arthritis pain and/or disability and improve quality of life are available in geographic pockets across the US but are still underused by people who can benefit from them2. Lack of awareness about AAEBIs, their benefits, and how to access them remain a challenge and a barrier to participation in these programs. More AAEBI offerings are needed, with greater geographic dispersion; and greater awareness to increase participation in them. This NOFO will leverage and expand existing systems, technologies and networks with national reach and/or access into large segments of the adult population to sustainably increase awareness and availability of and participation in AAEBIs. It will also support technical assistance to state health departments and provision of arthritis-specific consumer health information to the public. Further, it will facilitate collaborative action to address osteoarthritis (OA) and address health equity and social determinants affecting AAEBI awareness and access and adoption of effective self-management behaviors. Lastly, it will support development of a national strategy targeted at healthcare providers to complement pharmacological treatments by specifically emphasizing adjunct self-management and physical activity approaches. The NOFO goals are to enhance the health, wellness, and quality of life of adults with arthritis and improve arthritis management and health outcomes. References:Barbour KE, Helmick CG, Boring M, Brady TJ. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013-2015. MMWR 2017;66(9):246-253.Barbour, K. E., Helmick, C. G., Boring, M., & Brady, T. J. (2017). Vital signs: prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013–2015. MMWR 2017;66(9):246.Hootman JM, Helmick CG, Barbour KE, Theis KA, Boring MA. Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015-2040. Arthritis Rheumatol. 2016;68(7):1582-7.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Michele Mercier
zaf5@cdc.gov
Email:zaf5@cdc.gov

DISPLAYING: Synopsis 4

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-DP21-2106
Funding Opportunity Title: Advancing Arthritis Public Health Priorities through National Organizations
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 7
Assistance Listings: 93.945 — Assistance Programs for Chronic Disease Prevention and Control
Cost Sharing or Matching Requirement: No
Version: Synopsis 4
Posted Date: Jan 14, 2021
Last Updated Date: Mar 23, 2021
Original Closing Date for Applications:
Current Closing Date for Applications: Apr 05, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: May 05, 2021
Estimated Total Program Funding: $10,185,595
Award Ceiling: $1,000,000
Award Floor: $150,000

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
State governments
For profit organizations other than small businesses
City or township governments
Independent school districts
Native American tribal governments (Federally recognized)
Private institutions of higher education
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Small businesses
County governments
Special district governments
Additional Information on Eligibility: This NOFO has two Components. Component 1 is focused on Building Capacity & Scaling Up whereas Component 2 is focused on Innovation. Applicants may apply for either or both Component 1 or Component 2. Component 1 applicants must select only one of the four options (A, B, C or D). Applicants must identify the Component they are applying for in the title of their application submission. If not clearly identified, the application will be considered non-responsive and will not be entered into the review process. A separate application must be submitted for each Component if applying for more than one.

Applicants are required to submit a budget within the range noted for each Component and corresponding strategy. If the proposed budget exceeds the Component and Strategy funding range, the application will be considered non-responsive and will not be entered into the review process.

Component 1 Funding Range:

Strategy A – $300K-$500K
Strategy B – $150K-$250K
Strategy C – $400K-$500K
Strategy D – $200K-$300K

Component 2 Funding Range – $300K-$500K

Additional Information

Agency Name: Centers for Disease Control – NCCDPHP
Description: The CDC Arthritis Program is announcing a new, FY21 non-research NOFO designed to improve health and quality of life for people with arthritis. Arthritis is an oft overlooked, leading contributor to chronic disease burden and a top cause of morbidity, work limitations, and reduced quality of life. More than 54 million US adults1 have arthritis, half of whom are working age2; and 78 million are projected to have it by 20403. Arthritis is significant, not only because it limits physical function and quality of life, but because it commonly co-occurs with other chronic conditions that are leading causes of death, such as heart disease, diabetes, and obesity, and can interfere with management of these conditions through its effects on limiting physical activity (PA)2.
 
People with arthritis face barriers to PA such as fear of worsening arthritis pain and progression2. However, arthritis and its limitations can be managed effectively, and symptoms improved through routine PA and participation in self-management education (SME) programs2. Low-cost, arthritis-appropriate, evidence-based interventions (AAEBIs) shown to decrease arthritis pain and/or disability and improve quality of life are available in geographic pockets across the US but are still underused by people who can benefit from them2. Lack of awareness about AAEBIs, their benefits, and how to access them remain a challenge and a barrier to participation in these programs. More AAEBI offerings are needed, with greater geographic dispersion; and greater awareness to increase participation in them.
 
This NOFO will leverage and expand existing systems, technologies and networks with national reach and/or access into large segments of the adult population to sustainably increase awareness and availability of and participation in AAEBIs. It will also support technical assistance to state health departments and provision of arthritis-specific consumer health information to the public. Further, it will facilitate collaborative action to address osteoarthritis (OA) and address health equity and social determinants affecting AAEBI awareness and access and adoption of effective self-management behaviors. Lastly, it will support development of a national strategy targeted at healthcare providers to complement pharmacological treatments by specifically emphasizing adjunct self-management and physical activity approaches. The NOFO goals are to enhance the health, wellness, and quality of life of adults with arthritis and improve arthritis management and health outcomes.
 
References:

Barbour KE, Helmick CG, Boring M, Brady TJ. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013-2015. MMWR 2017;66(9):246-253.
Barbour, K. E., Helmick, C. G., Boring, M., & Brady, T. J. (2017). Vital signs: prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013–2015. MMWR 2017;66(9):246.
Hootman JM, Helmick CG, Barbour KE, Theis KA, Boring MA. Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015-2040. Arthritis Rheumatol. 2016;68(7):1582-7.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Michele Mercier
zaf5@cdc.gov
Email:zaf5@cdc.gov

DISPLAYING: Synopsis 3

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-DP21-2106
Funding Opportunity Title: Advancing Arthritis Public Health Priorities through National Organizations
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 7
Assistance Listings: 93.945 — Assistance Programs for Chronic Disease Prevention and Control
Cost Sharing or Matching Requirement: No
Version: Synopsis 3
Posted Date: Jan 14, 2021
Last Updated Date: Feb 26, 2021
Original Closing Date for Applications:
Current Closing Date for Applications: Apr 05, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: May 05, 2021
Estimated Total Program Funding: $10,185,595
Award Ceiling: $1,000,000
Award Floor: $150,000

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
State governments
For profit organizations other than small businesses
City or township governments
Independent school districts
Native American tribal governments (Federally recognized)
Private institutions of higher education
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Small businesses
County governments
Special district governments
Additional Information on Eligibility: This NOFO has two Components. Component 1 is focused on Building Capacity & Scaling Up whereas Component 2 is focused on Innovation. Applicants may apply for either or both Component 1 or Component 2. Component 1 applicants must select only one of the four options (A, B, C or D). Applicants must identify the Component they are applying for in the title of their application submission. If not clearly identified, the application will be considered non-responsive and will not be entered into the review process. A separate application must be submitted for each Component if applying for more than one.

Applicants are required to submit a budget within the range noted for each Component and corresponding strategy. If the proposed budget exceeds the Component and Strategy funding range, the application will be considered non-responsive and will not be entered into the review process.

Component 1 Funding Range:

Strategy A – $300K-$500K
Strategy B – $150K-$250K
Strategy C – $400K-$500K
Strategy D – $200K-$300K

Component 2 Funding Range – $300K-$500K

Additional Information

Agency Name: Centers for Disease Control – NCCDPHP
Description: The CDC Arthritis Program is announcing a new, FY21 non-research NOFO designed to improve health and quality of life for people with arthritis. Arthritis is an oft overlooked, leading contributor to chronic disease burden and a top cause of morbidity, work limitations, and reduced quality of life. More than 54 million US adults1 have arthritis, half of whom are working age2; and 78 million are projected to have it by 20403. Arthritis is significant, not only because it limits physical function and quality of life, but because it commonly co-occurs with other chronic conditions that are leading causes of death, such as heart disease, diabetes, and obesity, and can interfere with management of these conditions through its effects on limiting physical activity (PA)2.
 
People with arthritis face barriers to PA such as fear of worsening arthritis pain and progression2. However, arthritis and its limitations can be managed effectively, and symptoms improved through routine PA and participation in self-management education (SME) programs2. Low-cost, arthritis-appropriate, evidence-based interventions (AAEBIs) shown to decrease arthritis pain and/or disability and improve quality of life are available in geographic pockets across the US but are still underused by people who can benefit from them2. Lack of awareness about AAEBIs, their benefits, and how to access them remain a challenge and a barrier to participation in these programs. More AAEBI offerings are needed, with greater geographic dispersion; and greater awareness to increase participation in them.
 
This NOFO will leverage and expand existing systems, technologies and networks with national reach and/or access into large segments of the adult population to sustainably increase awareness and availability of and participation in AAEBIs. It will also support technical assistance to state health departments and provision of arthritis-specific consumer health information to the public. Further, it will facilitate collaborative action to address osteoarthritis (OA) and address health equity and social determinants affecting AAEBI awareness and access and adoption of effective self-management behaviors. Lastly, it will support development of a national strategy targeted at healthcare providers to complement pharmacological treatments by specifically emphasizing adjunct self-management and physical activity approaches. The NOFO goals are to enhance the health, wellness, and quality of life of adults with arthritis and improve arthritis management and health outcomes.
 
References:

Barbour KE, Helmick CG, Boring M, Brady TJ. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013-2015. MMWR 2017;66(9):246-253.
Barbour, K. E., Helmick, C. G., Boring, M., & Brady, T. J. (2017). Vital signs: prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013–2015. MMWR 2017;66(9):246.
Hootman JM, Helmick CG, Barbour KE, Theis KA, Boring MA. Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015-2040. Arthritis Rheumatol. 2016;68(7):1582-7.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Michele Mercier
zaf5@cdc.gov
Email:zaf5@cdc.gov

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-DP21-2106
Funding Opportunity Title: Advancing Arthritis Public Health Priorities through National Organizations
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 7
Assistance Listings: 93.945 — Assistance Programs for Chronic Disease Prevention and Control
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Jan 14, 2021
Last Updated Date: Jan 20, 2021
Original Closing Date for Applications:
Current Closing Date for Applications: Apr 05, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: May 05, 2021
Estimated Total Program Funding: $10,185,595
Award Ceiling: $1,000,000
Award Floor: $150,000

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
State governments
For profit organizations other than small businesses
City or township governments
Independent school districts
Native American tribal governments (Federally recognized)
Private institutions of higher education
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Small businesses
County governments
Special district governments
Additional Information on Eligibility: This NOFO has two Components. Component 1 is focused on Building Capacity & Scaling Up whereas Component 2 is focused on Innovation. Applicants may apply for either or both Component 1 or Component 2. Component 1 applicants must select only one of the four options (A, B, C or D). Applicants must identify the Component they are applying for in the title of their application submission. If not clearly identified, the application will be considered non-responsive and will not be entered into the review process. A separate application must be submitted for each Component if applying for more than one.

Additional Information

Agency Name: Centers for Disease Control – NCCDPHP
Description: The CDC Arthritis Program is announcing a new, FY21 non-research NOFO designed to improve health and quality of life for people with arthritis. Arthritis is an oft overlooked, leading contributor to chronic disease burden and a top cause of morbidity, work limitations, and reduced quality of life. More than 54 million US adults1 have arthritis, half of whom are working age2; and 78 million are projected to have it by 20403. Arthritis is significant, not only because it limits physical function and quality of life, but because it commonly co-occurs with other chronic conditions that are leading causes of death, such as heart disease, diabetes, and obesity, and can interfere with management of these conditions through its effects on limiting physical activity (PA)2. People with arthritis face barriers to PA such as fear of worsening arthritis pain and progression2. However, arthritis and its limitations can be managed effectively, and symptoms improved through routine PA and participation in self-management education (SME) programs2. Low-cost, arthritis-appropriate, evidence-based interventions (AAEBIs) shown to decrease arthritis pain and/or disability and improve quality of life are available in geographic pockets across the US but are still underused by people who can benefit from them2. Lack of awareness about AAEBIs, their benefits, and how to access them remain a challenge and a barrier to participation in these programs. More AAEBI offerings are needed, with greater geographic dispersion; and greater awareness to increase participation in them. This NOFO will leverage and expand existing systems, technologies and networks with national reach and/or access into large segments of the adult population to sustainably increase awareness and availability of and participation in AAEBIs. It will also support technical assistance to state health departments and provision of arthritis-specific consumer health information to the public. Further, it will facilitate collaborative action to address osteoarthritis (OA) and address health equity and social determinants affecting AAEBI awareness and access and adoption of effective self-management behaviors. Lastly, it will support development of a national strategy targeted at healthcare providers to complement pharmacological treatments by specifically emphasizing adjunct self-management and physical activity approaches. The NOFO goals are to enhance the health, wellness, and quality of life of adults with arthritis and improve arthritis management and health outcomes. References:Barbour KE, Helmick CG, Boring M, Brady TJ. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013-2015. MMWR 2017;66(9):246-253.Barbour, K. E., Helmick, C. G., Boring, M., & Brady, T. J. (2017). Vital signs: prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013–2015. MMWR 2017;66(9):246.Hootman JM, Helmick CG, Barbour KE, Theis KA, Boring MA. Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015-2040. Arthritis Rheumatol. 2016;68(7):1582-7.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Michele Mercier
zaf5@cdc.gov
Email:zaf5@cdc.gov

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-DP21-2106
Funding Opportunity Title: Advancing Arthritis Public Health Priorities through National Organizations
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 7
Assistance Listings: 93.945 — Assistance Programs for Chronic Disease Prevention and Control
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jan 14, 2021
Last Updated Date: Jan 14, 2021
Original Closing Date for Applications:
Current Closing Date for Applications: Apr 05, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Archive Date: May 05, 2021
Estimated Total Program Funding: $10,185,595
Award Ceiling: $1,000,000
Award Floor: $150,000

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
State governments
For profit organizations other than small businesses
City or township governments
Independent school districts
Native American tribal governments (Federally recognized)
Private institutions of higher education
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Small businesses
County governments
Special district governments
Additional Information on Eligibility: This NOFO has two Components. Component 1 is focused on Building Capacity & Scaling Up whereas Component 2 is focused on Innovation. Applicants may apply for either or both Component 1 or Component 2. Component 1 applicants must select only one of the four options (A, B, C or D). Applicants must identify the Component they are applying for in the title of their application submission. If not clearly identified, the application will be considered non-responsive and will not be entered into the review process. A separate application must be submitted for each Component if applying for more than one.

Additional Information

Agency Name: Centers for Disease Control – NCCDPHP
Description: The CDC Arthritis Program is announcing a new, FY21 non-research NOFO designed to improve health and quality of life for people with arthritis. Arthritis is an oft overlooked, leading contributor to chronic disease burden and a top cause of morbidity, work limitations, and reduced quality of life. More than 54 million US adults1 have arthritis, half of whom are working age2; and 78 million are projected to have it by 20403. Arthritis is significant, not only because it limits physical function and quality of life, but because it commonly co-occurs with other chronic conditions that are leading causes of death, such as heart disease, diabetes, and obesity, and can interfere with management of these conditions through its effects on limiting physical activity (PA)2.

People with arthritis face barriers to PA such as fear of worsening arthritis pain and progression2. However, arthritis and its limitations can be managed effectively, and symptoms improved through routine PA and participation in self-management education (SME) programs2. Low-cost, arthritis-appropriate, evidence-based interventions (AAEBIs) shown to decrease arthritis pain and/or disability and improve quality of life are available in geographic pockets across the US but are still underused by people who can benefit from them2. Lack of awareness about AAEBIs, their benefits, and how to access them remain a challenge and a barrier to participation in these programs. More AAEBI offerings are needed, with greater geographic dispersion; and greater awareness to increase participation in them.

This NOFO will leverage and expand existing systems, technologies and networks with national reach and/or access into large segments of the adult population to sustainably increase awareness and availability of and participation in AAEBIs. It will also support technical assistance to state health departments and provision of arthritis-specific consumer health information to the public. Further, it will facilitate collaborative action to address osteoarthritis (OA) and address health equity and social determinants affecting AAEBI awareness and access and adoption of effective self-management behaviors. Lastly, it will support development of a national strategy targeted at healthcare providers to complement pharmacological treatments by specifically emphasizing adjunct self-management and physical activity approaches. The NOFO goals are to enhance the health, wellness, and quality of life of adults with arthritis and improve arthritis management and health outcomes.

References:

Barbour KE, Helmick CG, Boring M, Brady TJ. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013-2015. MMWR 2017;66(9):246-253.
Barbour, K. E., Helmick, C. G., Boring, M., & Brady, T. J. (2017). Vital signs: prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013–2015. MMWR 2017;66(9):246.
Hootman JM, Helmick CG, Barbour KE, Theis KA, Boring MA. Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015-2040. Arthritis Rheumatol. 2016;68(7):1582-7.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Michele Mercier
zaf5@cdc.gov
Email:zaf5@cdc.gov

DISPLAYING: Forecast 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-DP21-2106
Funding Opportunity Title: Advancing Arthritis Public Health Priorities through National Organizations
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 6
Assistance Listings: 93.945 — Assistance Programs for Chronic Disease Prevention and Control
Cost Sharing or Matching Requirement: Yes
Version: Forecast 1
Posted Date: Jul 29, 2020
Last Updated Date: Jul 29, 2020
Original Closing Date for Applications:
Current Closing Date for Applications:
Archive Date:
Estimated Total Program Funding: $10,185,595
Award Ceiling: $500,000
Award Floor: $200,000

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility: This NOFO has two Components. Component 1 is focused on Building Capacity & Scaling Up whereas Component 2 is focused on Innovation. Applicants may apply for either or both Component 1 or Component 2. Component 1 applicants may select only one strategy from the menu of four options. Applicants must identify the Component they are applying for in the title of their application submission.

Additional Information

Agency Name: Centers for Disease Control – NCCDPHP
Description: The CDC Arthritis Program is announcing a new, FY21 non-research NOFO designed to improve health and quality of life for people with arthritis. Arthritis is an oft overlooked, leading contributor to chronic disease burden and a top cause of morbidity, work limitations, and reduced quality of life. More than 54 million US adults1 have arthritis, half of whom are working age2; and 78 million are projected to have it by 20403. Arthritis is significant, not only because it limits physical function and quality of life, but because it commonly co-occurs with other chronic conditions that are leading causes of death, such as heart disease, diabetes, and obesity, and can interfere with management of these conditions through its effects on limiting physical activity (PA)2.

People with arthritis face barriers to PA such as fear of worsening arthritis pain and progression2. However, arthritis and its limitations can be managed effectively, and symptoms improved through routine PA and participation in self-management education (SME) programs2. Low-cost, arthritis-appropriate, evidence-based interventions (AAEBIs) shown to decrease arthritis pain and/or disability and improve quality of life are available in geographic pockets across the US but are still underused by people who can benefit from them2. Lack of awareness about AAEBIs, their benefits, and how to access them remain a challenge and a barrier to participation in these programs. More AAEBI offerings are needed, with greater geographic dispersion; and greater awareness to increase participation in them.

This NOFO will leverage and expand existing systems, technologies and networks with national reach and/or access into large segments of the adult population to sustainably increase awareness and availability of and participation in AAEBIs. It will also support technical assistance to state health departments and provision of arthritis-specific consumer health information to the public. Further, it will facilitate collaborative action to address osteoarthritis (OA) and address health equity and social determinants affecting AAEBI awareness and access and adoption of effective self-management behaviors. Lastly, it will support development of a national strategy targeted at healthcare providers to complement pharmacological treatments by specifically emphasizing adjunct self-management and physical activity approaches. The NOFO goals are to enhance the health, wellness, and quality of life of adults with arthritis and improve arthritis management and health outcomes.

References:

Barbour KE, Helmick CG, Boring M, Brady TJ. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013-2015. MMWR 2017;66(9):246-253.
Barbour, K. E., Helmick, C. G., Boring, M., & Brady, T. J. (2017). Vital signs: prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2013–2015. MMWR 2017;66(9):246.
Hootman JM, Helmick CG, Barbour KE, Theis KA, Boring MA. Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015-2040. Arthritis Rheumatol. 2016;68(7):1582-7.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:


Email:zaf5@cdc.gov

Folder 328396 Full Announcement-FULL_ANNOUNCEMENT -> CDC-RFA-DP21-2106.pdf

Folder 328396 Revised Full Announcement-Revised Full Announcement -> Foa_Content_of_CDC-RFA-DP21-2106 (11).pdf

Folder 328396 Revised Full Announcement-Revised Full Announcement -> Foa_Content_of_CDC-RFA-DP21-2106 (8).pdf

Folder 328396 Revised Full Announcement-Revised Full Announcement -> Foa_Content_of_CDC-RFA-DP21-2106 (9).pdf

Packages

Agency Contact Information: Michele Mercier
zaf5@cdc.gov
Email: zaf5@cdc.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.945 CDC-RFA-DP21-2106 Advancing Arthritis Public Health Priorities through National Organizations PKG00264961 Jan 14, 2021 Aug 13, 2021 View

Package 1

Mandatory forms

328396 SF424_3_0-3.0.pdf

328396 Project_AbstractSummary_2_0-2.0.pdf

328396 SFLLL_2_0-2.0.pdf

328396 SF424A-1.0.pdf

328396 BudgetNarrativeAttachments_1_2-1.2.pdf

328396 ProjectNarrativeAttachments_1_2-1.2.pdf

Optional forms

328396 OtherNarrativeAttachments_1_2-1.2.pdf

2025-07-14T11:46:42-05:00

Share This Post, Choose Your Platform!

About the Author: